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SUMMARY 
 
The entire genomic sequence of the AaΦ23 bacteriophage is presented. Its size is 
43,033 bp and it has an overall molar G+C content of 41mol%. 57 potential open reading 
frames (ORFs) were identified. A putative function could be assigned to 20 of the 57 ORFs, 
i.e. to 35% of them. While another 25 ORFs share homologies with hypothetical proteins 
present in several bacteria or bacteriophages, 12 seem to be specific for the phage AaΦ23. 
Based on the genetic organization of its genome, AaΦ23 shares extensive similarities with 
lambdoid bacteriophages. Most functions described for lambda are also found on the AaΦ23 
genome. We identified potential ORFs coding for the integrase mediating recombination at 
the attachment sites; the generalized recombination proteins ninB and ninG; both C1 and Cro 
regulators of lysogeny; the replication proteins O and P; the antitermination protein Q; two 
components of the lytic system; structural components of the virion head, tail, baseplate and 
tail fibers and both subunits of the terminase enzyme involved in DNA packaging. 
The sequence of the phage attachment site (attP) is located 19 bp upstream of the gene 
coding for the integrase. The attL and attR of two lysogenic A. actinomycetemcomitans 
strains and the attB sites in two non-lysogenic strains were also identified. The common att 
core is 49 bp in length.  
No gene coding for a known virulence factor was detected on the AaΦ23 genome. However, 
a DNA adenine methylase was characterized that may be functionally expressed from the 
prophage. This protein is of particular interest because DNA adenine methylase enzymes are 
involved in the virulence of several bacterial pathogens such as Salmonella typhimurium, 
Yersinia pseudotuberculosis, and Vibrio cholerae. Still, presence of ORFs coding for proteins 
modulating the A. actinomycetemcomitans pathogenicity cannot be exclude as no putative 
function was assigned to 37 ORFs. 
 7 
Preliminary data on the putative lytic enzyme of AaΦ23 suggest that expression, even at low 
level, of the cloned lys gene is lethal for Escherichia coli cells. 
Location on the genetic map, amino acid sequence homologies and conservation of structural 
key residues strongly suggest that the integrase is coded by orf1. Preliminary data on the 
functional characterization were inconclusive. Delineation of the integration elements of 
AaΦ23 will allow the construction of an integration vector for A. actinomycetemcomitans. 
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INTRODUCTION 
 
Pathogenesis of periodontal diseases 
Periodontal disease is a general term used to describe inflammatory processes in the 
periodontium caused by bacterial plaque accumulation. Microorganisms contained in the 
bacterial plaque are the primary etiologic agents of the different forms of periodontitis, 
namely localized juvenile periodontitis (LJP), adult periodontitis (AP) and rapidly 
progressive periodontitis (RPP). LJP is an early-onset periodontitis principally involving the 
permanent first molar and incisor teeth. LJP starts during the circumpubertal period of life 
and often results in tooth loss prior to age 20. The prevalence and severity of periodontal 
disease increase over time with inadequate oral hygiene (Löe et al. 1978). A positive 
correlation between the amount of microbial plaque and the degree of gingival inflammation 
has been demonstrated and this inflammation was reversible by removing the plaque from the 
teeth (Löe et al. 1965). However, it is not clear how much of the destruction of periodontal 
tissue is caused by direct effects of the bacteria and how much is due to the immune response 
of the host against the bacterial invasion. Periodontitis evolves in four distinct steps : the 
initial, the early, the established and the advanced lesion that is generally viewed as the 
periodontitis status (Page and Schroeder 1976). In response to bacterial plaque proliferation 
in the sulcus during the initial and early stages, leukocytes (predominantly neutrophils) 
migrate in the junctional epithelium and underlying tissue. Neutrophils, within the crevices, 
can phagocytose and digest bacteria but if they become overloaded they degranulate. 
Bacterial toxins secretion and release of enzymes following the neutrophils degranulation 
causes tissue damage and leads to collagen and fibroblast alteration in the marginal gingiva 
and to proliferation of basal cells of the junctional epithelium. In the established lesion the 
inflammatory infiltrate is characterized by the predominance of plasmocytes and by several 
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modifications of the milieu : secretion of antibodies, activation of the complement by 
opsonized antigens, production of several interleukines (notably IL1) and increase of the 
production of inflammatory prostaglandine E2. The junctional epithelium extends apically 
and inflammatory cells migrate deeper in the sulcus thus forming a periodontal pocket. Later 
in the advanced stage, anaerobic microorganisms accumulate deeper in the pocket, some of 
which produce tissue-destructing enzymes like collagenases and/or toxins. Collagen 
destruction and junctional epithelium migration continues. Exacerbation of the inflammatory 
response leads to bone loss by activation of osteoclast cells. 
Certain genetic and environmental factors such as compromised immunity, hormonal factors 
and smoking are thought to be risk factors for periodontal diseases (Page and Kornman 
1997). 
 
Bacteriology of periodontal diseases 
The oral cavity represents an ecological niche for a large number of bacteria. In fact, 
to date, more than 500 cultivable bacterial species have been isolated from the gingival 
crevices (Moore and Moore 1994) and this number may be doubled if we take under 
consideration the non-cultivable and non-identified bacteria (Wilson et al. 1997). 
Facultatively anaerobic Gram–positive strains are predominant in the supragingival dental 
plaque of healthy subjects. In gingivitis, the proportion of Gram-negative anaerobic species 
increase. Of the many species present in the mouth, only 10 to 30 are putative periodonto-
pathogens (Socransky and Haffajee 1994), but are all also found in periodontally healthy 
individuals. Only three species, Actinobacillus actinomycetemcomitans, Porphyromonas 
gingivalis and Bacteroides forsythus are at present considered to play an important etiological 
role in the initiation of periodontal diseases (World Workshop in Periodontics 1996). 
Additional putative periodontal pathogens include Fusobacterium nucleatum, Prevotella 
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intermedia, Prevotella nigrescens and several spirochetes (Haffajee and Socransky 1994, 
World Workshop in Periodontics 1996). 
 
ACTINOBACILLUS ACTINOMYCETEMCOMITANS 
 
General characteristics 
A. actinomycetemcomitans is a Gram-negative coccobacillus, member of the family 
Pasteurellaceae which has been describe for the first time in 1912 by Klinger as Bacterium 
actinomycetem comitans (Klinger 1912). It is non-motile, facultatively anaerobic and 
capnophilic. It is cultivated on agar plates, supplemented with human blood. It grows into 
small colonies within 48 to 72 h. On agar plates, circular colonies are rough, translucent with 
a star-shaped morphology. Bacteria adhere together and to the agar plate with their frimbriae 
(Rosan et al. 1988). After repeated subculture, the rough phenotype is lost and a smooth 
phenotype appears with a decrease of adherence (Inouye et al. 1990). This bacterium is most 
closely related to Haemophilus aphrophilus and Haemophilus paraphrophilus species (for 
review see Zambon 1985) but does not require X (hemin) or V (nicotinamide adenine 
dinucleotide) growth factors (Slots 1982). 
A. actinomycetemcomitans isolates were further characterized by several typing methods. 
Serotyping revealed six different serotypes, named a to e (Zambon et al. 1983) and more 
recently f (Kaplan et al. 2001). Three to nine % of the A. actinomycetemcomitans strains 
characterized did not react with any of the serotype-specific antisera tested and were 
therefore classified as non-serotypeable strains (Paju et al. 1998). Generally only one 
serotype is isolated from one patient (Zambon et al. 1983). Serotypes b (Asikainen et al. 
1991, Zambon et al. 1990, Zambon et al. 1983) or c (Tinoco et al. 1997) are most frequently 
associated with LJP or AP. Serotype c is also found in more than 70% among isolates of 
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healthy persons (Asikainen et al. 1991) and in non-oral infections (Zambon et al. 1988). 
Other typing methods like analysis of restriction enzyme digestions and ribotyping confirmed 
the heterogeneity among the species A. actinomyctemcomitans (van Steenbergen et al. 1994). 
 
A. actinomycetemcomitans as a periodontal pathogen 
A. actinomyctemcomitans is tought to play a role as primary etiologic agent in LJP 
because it fulfills Socransky’s postulates (1979) which identify periodontal pathogens:  
 A. actinomycetemcomitans is present in increased numbers or proportions in diseased 
sites and in lower numbers or even below detection level in healthy sites (Zambon et 
al. 1983, Slots et al. 1980). 
 Its elimination or suppression by mechanical treatment or chemotherapy brings the 
disease progression to a halt, whereas recurrence of the disease is directly correlated 
with the reappearence of the bacterium in periodontal sites (van Winkelhoff and de 
Graaff 1991, Slots and Rosling 1983). 
 A detectable specific immune response to A. actinomycetemcomitans is found in 
diseased patients (Ebersole et al. 1982, Ranney et al. 1982, Genco et al. 1980). 
 It can induce a periodontal disease in animals upon experimental infection (Beighton 
et al. 1989). However, animal models differ in several aspects from the human 
disease. 
 Several putative virulence factors, such as a leukotoxin (Mangan et al.1991), a 
hemolysin (Kimizuka et al. 1996), a lipopolysaccharide (Kiley and Holt 1980), a 
bacteriocin (Hammond et al. 1987), cytolethal distending toxins (Mayer et al. 1999) 
and several others (for review see Fives-Taylor et al. 1999), have been identified for 
this bacterium. 
 
 12 
A. actinomycetemcomitans in non-oral infections  
In the literature several studies reported the recovery of A. actinomycetemcomitans 
from infections of other body sites and organs than the oral cavity, for examples, brain 
abscesses, heart infections and endocarditis (van Winkelhoff and Slots 1999). Thus, A. 
actinomycetemcomitans is able to mediate focal infections. 
 
Genome sequencing project of the A. actinomycetemcomitans strain 
HK1651. 
The genome of the A. actinomycetemcomitans strain HK1651, a clinical isolate obtained from 
Mogens Kilian (University of Aarhus, Denmark), has been sequenced at the Advanced Center 
for Genome Technology of the Oklahoma’s University (unpublished results). This sequence 
consisting of 2,105,329 bp can be obtained by file transfer protocol on the following internet 
site (http://www.genome.ou.edu/act.html). 
 
BACTERIOPHAGES 
 
Definition of bacteriophages 
First observed by Frederick Twort (1915) and, independently (Duckworth 1976), by 
Félix d’Hérelle (1917), bacteriophages (bacteria-eater) are simple viruses consisting of a 
nucleic acid molecule (single or double-stranded RNA or DNA) enveloped in a protein shell, 
the capsid (Schlesinger 1936). The main distinction with other viruses is their host range. In 
fact, bacteriophages are obligate intracellular parasites that propagate only within a bacteria 
host cell. Two types of bacteriophages are distinguished. The lytic phages (like E. coli phage 
T4) on the one hand, kill and lyse their hosts after replication, and the temperate 
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bacteriophages (like E. coli phage lambda) on the other, which in addition can lysogenize 
their hosts. After circularisation, the double-stranded DNA is integrated, by a site-specific 
recombination process, within the host chromosome (Campbell 1962). This integrated 
bacteriophage genome represents a prophage and is replicated along with the host cell 
chromosome as the lysogenized cell grows and divides. Repression of the viral genes 
required for lytic replication is maintained in progeny cells. However, these prophages can 
initiate a lytic cycle either spontaneously, or after induction by mitomycin C treatment, UV-
light irradiation or X-rays. 
 
Classification of bacteriophages  
Phages are classified with respect to their morphology and properties of their nucleic 
acid genomes. They are indexed in the Universal Virus Database of the International 
Committee on Taxonomy of Viruses (http://www.ictvdb.rothamsted.ac.uk/index.htm). The 
last phage survey has been realised in the year 2000 at the Félix D’Hérelle Reference Center 
for Bacterial Viruses, Quebec, Canada (Ackermann 2001). More than 5000 bacteriophages 
have been observed under the electron microscope since 1959. 96% are tailed phages and 
only 186 (3,6%) have a cubic, filamentous or pleïomorphic morphology. Phages have been 
assigned to 13 families; they have been isolated from about 140 bacterial and several archaeal 
genera. The most frequently represented family is the Siphoviridae that comprizes 61% of the 
4950 tailed phages.  
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Importance of bacteriophages 
 
Ecological importance of bacteriophages 
Bacteriophages are considered as being more numerous than any other organism in 
the biosphere, prokaryotes included. They are found in all ecosystems. The major quantity is 
found in the coastal oceanic waters at a density of 106 particles per ml but significant 
quantities are also found in soil and in the gut of mammals. The population of only the tailed 
phage on earth is estimated to be 1030 virion particles (Wommack and Colwell 2000). 
 
Economical importance of bacteriophages 
In the dairy industries, many different lactobacilli are used in the production of dairy 
products such as cheese and yoghurt. Infections of Lactobacilllus species by lytic 
bacteriophages could lead to the arrest of fermentations and thereby loss of production 
(Brüssow 2001). Phages have also been shown to interfere with the industrial production of 
amino acids from coryneform bacteria (Hongo et al. 1972) and bacitracin from Bacillus 
licheniformis (Tran et al. 1999). 
 
Medical importance of bacteriophages  
 
Role of bacteriophages in the horizontal transfer of bacterial virulence 
genes 
Bacteriophages are mediators of horizontal gene transfer, called transduction, 
whereby a genetic trait is carried by phage particles from a bacterial donor to a recipient cell. 
Specialized and generalized transduction processes were recently summarized (Birge 2000). 
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In specialized transducing phages (Lambda, φ80) bacterial chromosomal sequences are 
covalently linked with the phage genome and are thus packaged into bacteriophage heads. 
Most frequently the genes flanking the integration site(s) are excised from the host 
chromosome along with the prophage. Many toxin genes are transduced, e.g. the 
staphylokinase and enterotoxin A from Staphylococcus aureus (Coleman et al. 1989), the 
erythrogenic toxins from Streptococcus pyogenes (Johnson et al. 1986) the diphtheria toxin 
produced by Corynebacterium diphtheriae (Laird and Groman 1976) and the cytotoxin 
encoded by phi CTX of Pseudomonas aeruginosa (Hayashi et al. 1993). The genes are 
located close to the bacteriophage attachment site, suggesting that these phages may have 
evolved as specialized transducing phages.  
In generalized transducing phages (P22, P1) phage heads usually contain only bacterial DNA 
packaged from any chromosomal location. These phages are non-infectious, i.e., they can 
inject DNA but it is not replicated. If this DNA is not integrated into the host chromosome, it 
is lost but may be expressed transiently (abortive transduction). Finally, plasmid transduction 
can also occur when plasmid DNA is packaged into transducing phages.  
The Vibrio pathogenicity island (VPI), which contains the gene coding for the receptor of the 
cholera toxin encoding filamentous phage CTXphi, can be transferred between Vibrio 
cholerae strains of the O1 serogroup via the generalized transducing phage CT-P1 (O’Shea 
and Boyd 2002). 
 
Bacteriophages as therapeutical agents 
Soon after the observation of the “bacteriophage phenomenon” and the description of 
plaque assays (d’Hérelle 1917), bacteriophages were tested as antibacterial agents in several 
infectious diseases as for example, typhoid fever (Davison 1922), bacillary dysentery 
(Beckerich and Haudroy 1922), cholera (Morrison 1932) and in Staphylococcus infections 
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(Brunoghe and Maisin 1921). The hopes were great and a first extensive review dealing with 
phage therapy was published in 1934 (Eaton and Stanhope 1934), when the exact nature of 
the so-called “bacteriophage” was not known. While d’Hérelle suspected a living organism 
he described as an “invisible microbe”, Twort and several other eminent scientists postulated 
an enzyme produced by bacterial activity. Answers to the question of the bacteriophage 
nature came in 1936 when Schlesinger reported the composition of bacteriophage particles 
being 50% proteins and 50% nucleic acid (Schlesinger 1936) and later with the first electron 
microscopy observation of bacteriophages (Ruska 1940). In the following years, the “miracle 
antibacterial drugs”, called antibiotics, became available. Phage therapy research was stopped 
in Western countries but, under d’Hérelle’s influence, was continued in Eastern European 
countries, especially in the Ex-Soviet Union. In this country, more than 700 publications 
reporting the successful use of phages as therapeutic agents have been published and several 
phage preparations against the most common human pathogenic bacterial strains are available 
on the market. The increasing prevalence of multidrug-resistant bacterial pathogens led the 
Western scientific community to seriously re-thinking the potential applications of phages 
and phage-derived products in the treatment of certain infectious diseases. Promising results 
about the antibacterial properties of bacteriophages were recently published. A single 
injection of 3x108 PFU of a lytic phage strain, administred 45 h after injection of 109 CFU of 
vancomycin-resistant Enterococcus faecium was shown to rescue 100% (n=5) of the 
bacteremic mice (Biswas et al. 2002). Moreover, potential antibacterial properties of purified 
bacteriophage derived lytic enzymes were also tested. 5 ng of the purified bacteriophage C1 
lysin were able to eliminate group A streptococci from 9 heavily colonized mice (Nelson et 
al. 2001). 100 U and 1400 U of purified bacteriophage DP-1 lytic enzyme (Pal) were 
respectively able to kill, in vitro, 15 common serotypes of pneumococci and to reduce to 
undetectable level pneumococcal titers in the nasal wash of 18 previously intranasally 
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colonized mice (Loeffler et al. 2001). More recently, an injection of 50 U of the PlyG lysin 
isolated from the γ phage of Bacillus anthracis 15 minutes after infection showed a 
pronounced therapeutic effect in mice as 13 of the 19 animals previously inoculated with 
Bacillus cereus (106 cells) recovered fully (Schuch et al. 2002).  
 
Bacteriophages of Actinobacillus actinomycetemcomitans 
The first A. actinomycetemcomitans phage (ΦAa17) was demonstrated by mitomycin 
C induction of a leukotoxic A. actinomycetemcomitans strain, which was isolated from a 
patient with LJP (Stevens et al. 1982). The phage was classified in Bradley’s group A and its 
genome was found, by restriction fragments analysis, to be a double-stranded linear DNA 
molecule of 47kb (Stevens et al. 1993). No clear correlation between ΦAa17 infection 
susceptibility and the leukotoxin production by strains of A. actinomycetemcomitans was 
found in this study (n=12). Occurrence of phages in this bacterial species is widespread. A. 
actinomycetemcomitans bacteriophages have been isolated either from healthy (Willi et al. 
1997a, Haubek et al. 1997) or periodontally diseased patients (Barretto-Tinoco et al. 1997, Iff 
et al. 1997, Haubek et al. 1997, Sandmeier et al. 1995, Willi et al. 1993, Olsen et al. 1993, 
Preus et al. 1987a, Preus et al. 1987b). Whereas several authors suspected that bacteriophages 
might modulate the virulence of A. actinomycetemcomitans, no clear correlation has been 
established between lysogeny in A. actinomycetemcomitans and severity of the disease. A. 
actinomycetemcomitans phages have been classified in Bradley’s groups A (Iff et al. 1997, 
Loftus and Delisle 1995, Sandmeier et al. 1995, Olsen et al. 1993, Preus et al. 1987a), B 
(Loftus and Delisle 1995, Olsen et al. 1993, Preus et al. 1987a) and C (Preus et al. 1987a). 
The majority of phages induced from A. actinomycetemcomitans belong to the Myoviridae 
family (Sandmeier et al. 1995, Willi et al. 1993). Five bacteriophages of A. 
actinomycetemcomitans isolated from periodontal pockets in three different European 
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countries, were genetically highly related and morphologically indistinguishable (Willi et al. 
1993). Among them, AaΦ23, derived from its natural lysogen A. actinomycetemcomitans 
strain ZIB1023, has been chosen as a representative of this family and has been studied in 
more detail. 
 
Bacteriophage AaΦ23 
The bacteriophage AaΦ23 has first been isolated from A. actinomycetemcomitans 
ZIB1023 (Willi et al. 1993). The virion has an isometric head of about 62 nm and a 
contractile tail of 112 nm, it belongs to the Myoviridae family (Willi et al. 1993). Restriction 
fragments analysis is in agreement with a physical circular map for the AaΦ23 DNA (Willi 
and Meyer 1998). Electron microscopy observations revealed that the phage genome 
comprises about 44 kb and that the DNA molecules contained in phage heads consist of a 
collection of molecules with a terminal redundancy of 1.6 kb which is circularly permuted 
(Willi and Meyer 1998). Southern blot experiments showed that the phage DNA integrates, 
as a prophage, into the host chromosome (Willi and Meyer 1998). The AaΦ23 prophage was 
found in about 40% of 259 strains derived from European isolates of A. 
actinomycemcomitans (Iff et al. 1997, Haubek et al. 1997, Willi et al. 1997a, Willi et al. 
1993). Occurrence of the AaΦ23 prophage was observed in strains isolated from periodontal 
disease as well as from healthy sites. No correlation between infection with AaΦ23 and 
severity of the periodontal disease was observed (Willi et al. 1997a). These results suggested 
that AaΦ23 prophages per se do not significantly increase the virulence of its host. Evidence 
was obtained that phage AaΦ23 is able to transfer antibiotic resistance markers by 
transduction (Willi et al. 1997b). 
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AIMS OF THE STUDY 
 
In order to learn more about the biology of this widespread phage, the first goal of the 
PhD work presented here was the sequencing of the entire double-stranded DNA molecule of 
bacteriophage AaΦ23. By this approach, genes coding for virulence factor which might have 
homologies with known virulence determinants would have been quickly identified. Chapter 
I present the complete genomic sequence of AaΦ23 and its annotation. Additionally, the 
bacteriophage attP and bacterial attB sites are reported in this Chapter. 
 
Identification of possible ORFs homologues to proteins that showed previously assigned 
functions guided our further work. 
 
 In Chapter II, the characterization of an AaΦ23 encoded DNA adenine 
methyltransferase is reported. 
 Chapter III and IV are two preliminary studies of the lytic enzyme and the putative 
integration elements of AaΦ23, respectively. 
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ABSTRACT 
 
The entire double-stranded DNA molecule that represents the Actinobacillus 
actinomycetemcomitans bacteriophage AaΦ23 genome was sequenced. DNA contained in the 
phage particles consists of a collection of linear molecules with a terminal redundancy which 
are circularly permutated. Therefore, the physical map of the phage genome is circular. Its 
size is 43,033 bp and it has an overall molar G+C content of 41 mol%. 57 potential open 
reading frames (ORFs) were identified. A putative function could be assigned to 20 of the 57, 
i.e. 35% of the ORFs. While 25 another ORFs share homologies with hypothetical proteins 
present in several bacteria or bacteriophages, 12 seem to be specific for phage AaΦ23. The 
putative organization of the phage genome shares extensive similarities to that of lambdoid 
phages. Similarities of AaΦ23 to lambdoid phages are also evident when considering 
sequence homologies of the lysogeny module (Integrase, C1/Cro regulators), the DNA 
replication system and the identified DNA adenine methyltransferase. One difference resides 
in the DNA packaging strategy that is more closely related to the P22 system. The putative 
lytic system of AaΦ23 seems to correspond to the one described for double stranded DNA 
bacteriophages of Gram-negative hosts. The attachment sites of AaΦ23 (attP) and of several 
A. actinomycetemcomitans strains (attB) were determined. 
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INTRODUCTION 
 
Actinobacillus actinomycetemcomitans is a capnophilic, non-motile Gram-negative 
bacterium, which has been strongly implicated in the etiology of localized juvenile 
periodontitis and certain forms of adult periodontitis (Meyer and Fives-Taylor 1997, Zambon 
1985). It is thought to play also a role in the establishment of other systemic diseases such as 
endocarditis (van Winkelhoff and Slots 1999). Although the mechanisms of pathogenicity are 
still not yet fully understood, several putative virulence factors including cytotoxic and 
immunosuppressive factors, the lipopolysaccharide, a bacteriocin, a collagenase, a 
chemotaxis-inhibiting factor and antibiotic-resistance factors have been described (Fives-
Taylor et al. 1999). The most extensively studied virulence factor of A. 
actinomycetemcomitans is its leukotoxin. This protein which is capable of lysing human 
polymorphonuclear leukocytes and macrophages, belongs to the group of repeat in toxin 
(RTX) family of bacterial cytotoxins (Lally et al. 1989). A large fraction of A. 
actinomycetemcomitans strains isolated from diseased sites were found to produce 
significantly more leukotoxin than isolates from healthy sites (Zambon 1985). Furthermore, 
many strains associated with LJP carry a deletion in the promoter region for the leukotoxin 
operon leading to higher production of the toxin (Contreras et al. 2000). 
Lysogeny is widespread in A. actinomycetemcomitans (Haubek et al. 1997, Sandmeier et al. 
1995). The first inducible bacteriophage, ΦAa17, was isolated from a leukotoxic strain 
(Stevens et al. 1982). Since then, lysogenic A. actinomycetemcomitans have been isolated 
from periodontal pockets (Iff et al. 1997, Haubek et al. 1997, Sandmeier et al. 1995) as well 
as from periodontally healthy individuals (Willi et al. 1997). The role of phages in the 
etiology of periodontal diseases is not yet clear. While some studies indicate a relation 
between phage-infected A. actinomycetemcomitans and rapidly destructive periodontitis 
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(Preus et al. 1987) others could not find such an association (Willi et al. 1997, Iff et al. 1997, 
Haubek et al. 1997). In several bacterial species, as Vibrio cholerae (Karaolis et al. 1999, 
Waldor and Mekalanos 1996) and Escherichia coli (Plunkett et al. 1999, Neely and Friedman 
1998) phage-encoded genes can modulate virulence.  
Phages released from several different A. actinomycetemcomitans lysogens possess an 
isometric icosahedral head of 65nm, a contractile tail of 110nm, a baseplate with up to four 
fibers (Iff et al. 1997, Willi et al. 1993) and therefore belong to the Myoviridae family (van 
Regenmortel et al. 2000). These phages are not only morphologically indistinguishable but 
also genetically related (Willi et al. 1993). To further our understanding of the biology of A. 
actinomycetemcomitans bacteriophages, we decided to sequence the entire genome of the 
bacteriophage AaΦ23 that naturally infects the A. actinomycetemcomitans strain ZIB1023 
(Willi et al 1993). DNA contained in  of this temperate phage particles consists of an 
approximately 45 kb double-stranded linear DNA molecule that is terminally redundant and 
circularly permuted.  
 
MATERIALS AND METHODS 
 
Bacterial strains, media, and culture conditions. A. actinomycetemcomitans ZIB1023 is 
the natural strain lysogenic for AaΦ23 (Willi et al. 1993). A. actinomycetemcomitans 
ZIB1001 represents a non lysogenic strain (Willi et al. 1993). A. actinomycetemcomitans 
HK1651 is a clinical isolate, the genome of which has been sequenced at the Advanced 
Center for Genome Technology (University of Oklahoma), obtained from Mogens Kilian 
(University of Aarhus, Denmark). ZIB1015 is a non-lysogenic strain and ZIB1515 
corresponds to the strain ZIB1015 that was experimentally lysogenized with the phage 
AaΦ23 (Willi et al. 1993). All strains were grown in Todd Hewitt Broth 3% (w/v) (BD 
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Biosciences, Allschwil, Switzerland) at 37°C in air and 10% CO2. Escherichia coli XL1 Blue 
electro-competent cells (Stratagene, Zürich, Switzerland) were used as hosts for plasmids 
pBluescript II SK-. E. coli XL1 Blue were grown in Luria-Bertani medium (LB, Sambrook et 
al. 1989) containing 100 µg/ml of ampicillin (Sigma, Buchs, Switzerland) at 37°C in air. 
 
Purification, cloning, and sequencing of the AaΦ23 genomic DNA. Phage DNA of 
AaΦ23 was prepared according to the procedure previously described (Willi et al. 1993). 
Briefly, after induction of phage release from a log-phase growing culture of A. 
actinomycetemcomitans strain ZIB1023 with mitomycin C (1 µg/ml), supernatant was treated 
with chloroform 1% (v/v). After addition of DNase (1 µg/ml) and RNase (1 µg/ml), phage 
particles were precipitated by polyethylene glycol 8000 and recovered by centrifugation. The 
phage DNA was subsequently extracted by phenol/chloroform and precipitated by ethanol. 
All chemicals and enzymes were purchased from Sigma. 
Phage DNA librairies were constructed by cutting the DNA with AluI, Cac8I, HaeIII or RsaI 
and shot-gun cloning of the DNA fragments into pBluescript II SK- digested with SmaI. The 
ligation mixtures were electroporated into E. coli XL1 Blue cells. Clones were frozen at –
70°C in THB supplemented with 10% (v/v) Hogness Freezing Medium (Werner et al. 1997). 
Plasmids were recovered with the help of the QIAwell 96 Ultra Plasmid Kit (Qiagen, Basel, 
Switzerland), following the recommendations of the manufacturer. Sequencing reactions 
were performed by using the ABI PRISM big-dye ready mix (Perkin Elmer, Langen, 
Germany) and analysed on an ABI PRISM 377 automated DNA sequencer (Perkin Elmer). 
Initially, T3 and T7 universal primers were used. The remaining gaps were closed either by 
primer walking on clones or phage genomic DNA or by sequencing of PCR amplified 
fragments covering the gaps. All restriction enzymes were obtained from Roche Diagnostics 
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AG (Rotkreuz, Switzerland) and oligonucleotides were purchased from Microsynth GmbH 
(Balgach, Switzerland). 
 
Sequence analysis and annotation. Sequences obtained were assembled by using the 
phred/phrap/consed software package. A total number of 289,652 bp, corresponding to an 
average coverage of the phage DNA of 6.7, was sequenced. The resulting consensus 
sequence was analysed by using the following software tools :ORF finder 
(http://www.ncbi.nlm.nih.gov/gorf/gorf.html), getorf 
(http://bioweb.pasteur.fr/seqanal/interfaces/getorf.html), blastn and blastp 
(http://www.ncbi.nlm.nih.gov/BLAST) against GENBANK and SWISSPROT databases, 
Webcutter 2.0 (http://www.firstmarket.com/cutter/cut2.html), Compute pI/MW 
(http://www.expasy.org/tools/pi_tool.html), ClustalW (http://npsa-pbil.ibcp.fr/cgi-
bin/npsa_automat.pl?page=npsa_clustalw.html), Interproscan 
(http://www.ebi.ac.uk/interpro/scan.html), einverted 
(http://bioweb.pasteur.fr/seqanal/interfaces/einverted.html), tRNAscan-SE 1.21 
(http://www.genetics.wustl.edu/eddy/tRNAscan-SE), FAStRNA 
(http://bioweb.pasteur.fr/seqanal/interfaces/fastrna.html), promoter prediction software 
(http://www.fruitfly.org/seq_tools/promoter.html) and several others from the GCG 
Wisconsin package (Genetics Computer Group, Accelrys Inc., Munich, Germany). 
Homologies to the genomic sequence of the A. actinomycetemcomitans strain HK1651 were 
determined using the blastn software available on the internet site of the Advanced Center for 
Genome Technology (Oklahoma University, USA, 
http://www.genome.ou.edu/act_blast.html). 
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Determination of the sequences of the attachment sites attP, attB, attL, and attR. The 
attB of strains ZIB1001 and 1015 were determined by using a semi-random polymerase chain 
reaction (SPCR). The protocol for the SPCR was obtained from the Roth Laboratory at the 
Division of Biological Sciences Section of Microbiology (University of California, Davis, 
http://rothlab.ucdavis.edu/protocols/semirandom.html). This protocol was adapted from 
Hermann et al. (2000). Primers used in this study are listed in Table 1. In the first step, the 
left and right ends of the integrated prophage and the flanking bacterial sequences from A. 
actinomycetemcomitans ZIB1023 and ZIB1515 were determined by SPCR amplification with 
SPCR primers 1 and 2 and sequencing from SPCR.seq primers 1 and 2. In the second step, 
SPCR primers 2, 3 and SPCR.seq primers 3 and 4 were designed based on the sequences 
obtained in the first step, and used to determine the sequence of the attB in the non-lysogenic 
A. actinomycetemcomitans strains ZIB1001 and ZIB1015. The attP site was determined by 
comparison of the determined attL, attR, and attB sites with the genomic sequence of 
AaΦ23. Moreover, the att core sequence was compared with the Genbank database and with 
the A. actinomycetemcomitans HK1651 genome. 
 
Table 1. List of the primers used to determine the sequence of the bacteriophage AaΦ23 integration sites. 
Primer  
name 
Oligonucleotide sequence 
of the primer (5’-3’) 
Hybridization 
site 
SPCR1 TATATGTGCTGCAAGAGTTGGGCGGG 204-229 on AaΦ23 
SPCR1.seq GCGCATTTATCTGTTGAGCAT 153-173 on AaΦ23 
SPCR2 CGTTTTATGAGGTTTGCATGTGTGTT 42879-42904 on AaΦ23 
SPCR2.seq TGATGACTACGATAAATTTATAAGCA 42959-42984 on AaΦ23 
SPCR3 CAATGGATGTCACCCTGGTCGGCATC 147955-147930 on HK1651 
SPCR3.seq ACGTGCCATTGATTTTATTAAAGCG 147900-147876 on HK1651 
SPCR4 CCGTTTAATTTAGACATGTTGTCTTCC 147401-147427 on HK1651 
SPCR4.seq TAACTTACTGAAGTGATTGTCTAG 147556-147579 on HK1651 
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Southern-blot experiments. Bacterial genomic DNA of A. actinomycetemcomitans strains 
ZIB1001, ZIB1023 and HK1651 was digested either with Asp700 or EcoRI and the 
restriction fragments were separated by gel electrophoresis on a 0.7% low-melting agarose 
gel (Bioconcept, Allschwil, Switzerland). DNA was transferred, by capillary blotting, onto a 
nylon membrane (Amersham Bioscience, Dübendorf, Switzerland). An Enhanced 
chemiluminescence method (Amersham Biosciences) was used for probe labeling, 
hybridization and detection, following the manufacturer protocols. 250 ng of the AaΦ23 
genomic DNA served as hybridization probe. 
 
Nucleotide accession number. The nucleotide sequence reported in this paper has been 
assigned accession number AJ560763 in the EMBL database. 
 
RESULTS AND DISCUSSION 
 
Nucleotide sequence of the AaΦ23 genome. The final consensus sequence obtained with 
phred/phrap/consed was circular. For convenience, the phage genome was linearized at the 
first nucleotide of the attP core sequence (Figure 1). The sequence of the AaΦ23 genome is 
composed of 43,033 bp. Virtual restriction maps of this sequence are in good agreement with 
the restriction maps previously obtained (Willi and Meyer 1998). These observations support 
the correct assembly of the sequences. The average G+C content of AaΦ23 is 41 mol%. This 
value is close to the 42.7 mol% reported for the A. actinomycetemcomitans genome (Kaplan 
and Fines 1998). This observation may suggest that phage AaΦ23 co-evolved since a long 
time with its host. 
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Gene prediction and organization of the AaΦ23 genome. Analysis of the AaΦ23 genome 
sequence predicted 56 genes with a minimal length of 300 nucleotides (Table 2). Although 
orf14 codes for a protein composed of only 68 amino acids, it was added to the genomic map 
because it may code for the Cro-like protein of AaΦ23 (Table 2). The genome is very 
condensed in terms of coding sequences as 93.7% of the entire genome are covered by 
potential coding regions and 19 gene are overlapping (Figure 1). Putative promoter sequences 
within 500 bp upstream of 49 of the 57 ORFs were identified (data not shown). No tRNA 
genes are present on the genome. Fifteen stem-loop like structures, that may represent rho-
independent transcription termination signals, have been identified (data not shown). The 
genome of AaΦ23 appears to be divided in two different regions (Figure 1). Most of the 13 
potential genes located in the left part of the genome (nucleotide 1 to 10121) are transcribed 
leftwards on the genetic map. In the right part of the genome (nucleotide 10122 to 43033) 39 
of the 44 potential genes are transcribed rightwards on the genetic map.  
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Figure 1. Schematic representation of Aa!23 genome. orfs are numbered consecutively from left to right and indicated by arrows pointing in the direction of transcription.
Black arrows represent genes transcribed rightwards and blue arrows represent genes transcribed leftwards on the map. Putative functions are indicated.
Red boxes indicate regions of homologies to the genome of the A. actinomycetemcomitans strain HK1651.
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Table 2. Description of bacteriophage AaΦ23 ORFs, gene product and functional assignments. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf1 1115 69 348 40.8 10.08 
Integrase 
(int) 
Integrase (phage ST64T, AAL15478.1, 3e-73)  
Integrase (phage P22, NP_059584.1, 5e-72)  
Putative phage integrase (Shigella flexneri 2a strain 301, AAN41973.1, 5e-72)  
Integrase (phage SfV, AAB72135.1, 2e-71) 
Integrase (phage DLP12, AAC73638.1, 3e-70)  
Integrase (phage SfX, AAD10295.1, 6e-69)  
P38 (phage APSE-1, NP_050999.1, 2e-66)  
Hypothetical protein (Xylella fastidiosa strain Dixon, ZP_00038220.1, 4e-63) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00042120.1, 4e-54) 
orf2 1336 989 115 13.2 9.38   
orf3 1666 1352 104 12.5 7.67  
Hypothetical protein (Actinobacillus actinomycetemcomitans strain 
HK1651,2e-55) 
orf4 2377 1721 218 12.5 6.72  Hypothetical protein (A. actinomycetemcomitans strain HK1651, e-113) 
orf5 2929 2444 161 33.2 5.65  Hypothetical protein  (A. actinomycetemcomitans strain HK1651, 6e-48) 
orf6 3760 3137 207 24.2 4.77   
orf7 4650 3757 297 18.5 9.11   
orf8 6226 5570 218 19.1 9.51  
Hypothetical protein (Haemophilus somnus strain 129PT, ZP_00123029.1, e-45) 
ORF14c (phage O395,AAN74016.1, 2e-25) 
P43 (phage APSE-1, NP_051004.1, e-22) 
Probable phage protein YPO2093 (Yersinia pestis strain CO92, AF0255, 4e-20)  
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00038185.1, 2e-18) 
Phage-related protein (X.. fastidiosa 9a5c, AAF84454.1, 5e-17) 
orf9 7138 7662 174 11.9 9.69  Hypothetical protein (A. actinomycetemcomitans strain HK651, 6e-78) 
orf10 7565 7125 146 13.2 9.38  Hypothetical protein (A. actinomycetemcomitans strain HK1651, e-68) 
orf11 8491 8018 157 18.3 8.95    
orf12 9347 8460 295 34 6.47   
* Isoelectric point 
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, e-value) 
orf13 10121 9405 250 28 5.01 
Repressor  
(c1) 
CI (phage phi-80, S04828, 7e-44) 
Probable transcription regulator PA0906 (Pseudomonas aeruginosa strain 
PAO1, E83531, 6e-43) 
Pectin lyase regulation DNA-binding protein (Pectobacterium carotovorum 
strain 71, AAA24865.1, 3e-39) 
Regulatory protein (Dichelobacter nodosus strain A198, CAA67160.1, 3e-39) 
Transcriptional regulator, Cro/CI family (phage lambdaSo, AAN56003.1, 5e-39) 
Pyocin regulatory protein prtR (P. aeruginosa strain PA01, A47062, 2e-38) 
orf14 10231 10429 68 7.2 9.8 
Repressor  
(cro) 
Hypothetical protein ydaS (Escherichia coli strain K12, H64885, 2e-06) 
Unknown protein (phage CP-933N, G85676, 3e-06) 
Unknown protein (Vibrio cholerae, AAL59694.1, 4e-05) 
Hypothetical protein XF0501 (X. fastidiosa strain 9a5c, AAF83311.1, e-04) 
Cro protein (phage 21, CAB39982.1, 5.2) 
Cro protein (phage P22 , AAA32268.1, 6.7) 
orf15 10410 10736 108 12.4 5.83  Hypothetical protein (A. actinomycetemcomitans strain HK1651, 3e-08) 
orf16 10788 11507 239 27.2 9.28 
Antirepressor  
(antB) 
Hypothetical protein (Azotobacter vinelandii strain , ZP_00089317.1, 2e-24) 
Hypothetical protein HI1422 (Haemophilus influenzae Rd strain KW20, 
E64029, 6e-24) 
Hypothetical protein (phage VT2-Sa, NP_050579.1, e-22) 
AntB (E. coli strain O157:H7, AAM53132.1, e-22) 
Putative antirepressor promoter (phage A118, CAB53832.1, 4e-22) 
Hypothetical protein (phage BP-933W, AAD25485.1, 5e-22) 
Putative antirepressor (phage ul36, AAM75755.1, 9e-22) 
orf17 11662 12444 260 30 7.08 
DNA replication  
protein 
(gene o) 
Protein GP18 (phage P22, Z8BPC2, e-18) 
Replication of DNA (phage Nil2, CAC95088.1, 4e-17) 
Gp54 (phage HK97, AAF31132.1, e-16) 
orf18 12049 11714 111 13.3 9.85   
* Isoelectric point 
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf19 12444 13901 485 54.7 5.9 
DNA 
Helicase 
(gene p) 
P protein (E. coli strain O157:H7, BAA94127.1, e-123)  
P protein (phage HK022, NP_050526.1, e-123) 
Replication protein P (phage HK620, NP_112058.1, e-123) 
Gp12 (phage ST64T, NP_720303.1, e-121) 
Replicative DNA helicase (Yersinia pestis strain KIM, AAM84165.1, 4e-72) 
Orf20 13904 14398 163 18.9 6.96 
DNA adenine 
methylase 
(dam) 
Hypothetical protein (H. somnus strain 129PT, ZP_00123655.1, 4e-20) 
dam (phage HP2, AAK37795.1, 5e-20) 
Putative adenine-specific methylase (phage HP1, P51715, 5e-20) 
Putative DNA methyltransferase (phage CP-933V, NP_288678.1, 3e-15) 
Hypothetical protein (phage Lahn3, CAC95062.1, 4e-15) 
Hypothetical protein (phage Nil2, CAC95095.1, 4e-15) 
Gp62 (phage HK97, AAF31137.1, 4e-15) 
Putative DNA methylase (E. coli strain O157:H7, NP_311008.1, 4e-15) 
DNA methylase (phage VT2-Sa, NP_050531.1, 5e-15) 
orf21 14405 14902 165 18.9 9.19 
Recombination 
 Protein 
(ninB) 
Unknown protein (phage HK620, NP_112060.1, 5e-30) 
Probable phage protein NinB (Y. pestis CO92, AB0255, e-17) 
Protein NinB (phage HK022, NP_597901.1, 2e-14) 
NinB protein (phage 21, CAB39988.1, 5e-14) 
Gp61 (phage HK97, NP_037743.1, 5e-14) 
Protein NinB (phage lambda, P03765, 9e-14) 
Hypothetical protein (phage Lahn3, CAC65061.1, 2e-13) 
NinB (phage P22, AAF75030.1, 3e-13) 
* Isoelectric point 
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf22 15495 16064 189 21.7 9.9 
Recombination  
Endonuclease 
(ninG) 
Hypothetical protein of (H. somnus strain 129PT, ZP_00122672.1, 6e-32) 
Recombination endonuclease (phage Nil2,CAC95102.1, 4e-25) 
Unknown protein (phage CP-933V, AAG57230.1, 3e-24) 
Protein NinG (phage lambda, P03770, 3e-24) 
Hypothetical protein (phage I, BAB87988.1, 6e-24) 
NinG (phage BP-933W, Q9ZWX1, 6e-24) 
NinG (phage 21, CAB39991.1, e-23) 
Unknown protein (phage LC159, AAN59917.1, 2e-23) 
Unknown protein (phage CP-933K, A85581, 2e-23) 
NinG (phage P22, Caa55163.1, 8e-22) 
orf23 16064 16435 123 14 9.61 
Anti-termination  
Protein 
 (gene q) 
Probable phage anti-termination protein Q (Y. pestis strain KIM, 
CAC90068.1, 7e-02) 
orf24 16725 17621 298 34 6.41 
Anti-repressor  
(ant) 
Putative anti-repressor protein (phage CP-933N, NP_287306.1, 5e-70) 
Putative anti-repressor protein (E. coli strain O157:H7, BAB34980.1, 5e-70) 
Putative phage anti-repressor (Y. pestis strain KIM, NP_669501.1, 3e-36) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041058.1, 4e-36) 
Gp30 (phage N15, NP_046925.1, 5e-27) 
Anti-repressor protein Ant (phage P22, NP_059643.1, 2e-25) 
Putative anti-repressor (Streptococcus pyogenes strain MGAS8232, 
AAL97393.1, 2e-17) 
Anti-repressor (phage A118, CAC95313.1, 2e-17) 
Hypothetical protein (H. somnus strain 129PT, ZP_00123653.1, 3e-17) 
orf25 17785 18231 148 16.3 5.52   
orf26 18228 18596 122 14 8.64   
orf27 18505 18870 121 13.1 9.1  Hypothetical protein HI1413 (H. influenzae strain Rd KW20, P44185, e-03) 
* Isoelectric point  
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf28 18939 19520 193 21.6 8.95 
Lytic enzyme 
(lys) 
Hypothetical protein HI1415 (H. influenzae strain Rd KW20, 
H64028, 2e-56) 
Lytic enzyme (P. aeruginosa strain PA01, BAA83137.1, 2e-33) 
Lytic enzyme, putative glycohydrolase (phage ST64B, 
NP_700425.1, 2e-28) 
Probable bacteriophage protein STY1042 (Salmonella enterica 
serovar typhimurium strain CT18, AI0620, 3e-26) 
Putative chitinase (phage Fels-1, NP_459884.1, 2e-25) 
Putative glycohydrolase (Deinococcus radiodurans strain R1, 
NP_285440.1, 6e-23) 
Hypothetical protein (Rhodopseudomonas 
palustris,ZP_00011491.1, 5e-22) 
Pyocin R2_PP, lytic enzyme (P. putida strain KT2440, 
NP_745210.1, 9e-21) 
Phage related lytic enzyme (Xanthomonas axonopodis pv. citri 
strain 306, NP_642961.1, 6e-20) 
orf29 19523 19855 110 12.6 9.41 
Rz lytic 
protein 
(rz) 
Hypothetical protein HI1414 (H. influenzae strain Rd KW20, 
P44186, e-15) 
Putative Rz lytic protein (phage SfV, AAL89453.1, e-3) 
* Isoelectric point 
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf30 20475 21035 186 21.1 5.21 
Terminase 
small  
subunit 
(terS) 
Hypothetical protein (Novosphingobium aromaticivorans, 
ZP_00096135.1, 2e-21) 
Putative terminase small subunit (phage 315.6, AAM80043.1, 3e-16) 
Subunit 1 of the terminase enzyme (phage rho15, CAA47712.1, 6e-13) 
Subunit 1 of the terminase enzyme (phage SF6, CAA47711.1, 6e-13) 
Hypothetical protein HI1411 (H. influenzae strain Rd KW20, 
Q57374, 5e-12) 
Terminase small subunit (H. influenzae strain Rd KW20, 
AAC23059.1, 5e-12) 
Terminase (Staphylococcus aureus strain Mu50, BAB56962.1, 8e-11) 
Terminase (phage bIL310, AAK08430.1, 7e-09) 
Probable terminase (phage phi-gle, T13203, 2e-08) 
Terminase small subunit (phage SPP1, NP_690652.1, 4e-08) 
Putative terminase small subunit (phage A118, CAB53787.1, 4e-08) 
orf31 20980 22443 487 54.7 8.48 
Terminase 
large 
subunit 
(terL) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00042224.1, e-65) 
Phage-related protein (X. fastidiosa strain Temecula1, AAO28853.1, e-65) 
Hypothetical protein (X. fastidiosa strain Dixon , ZP_00039342.1, 2e-65) 
Hypothetical protein (N. aromaticivorans, ZP_00094970.1, e-56) 
Terminase large subunit (phage Bcep781, AAN38019.1, e-50) 
Phage-related protein (Listeria innocua strain Clip11262, 
CAC96963.1, 5e-50) 
Phage-related protein XF1675 XF1570 (X. fastidiosa 9a5c, A82650, 3e-42) 
Hypothetical protein (X. fastidiosa Ann-1, ZP_00042155.1, e-38) 
Hypothetical protein BH3533 (Bacillus halodurans strain C-125, 
E84091, 6e-32) 
Putative terminase large subunit (phage ul36, NP_663671.1, 8e-32) 
* Isoelectric point 
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf32 22445 23758 437 49.1 4.71  
Hypothetical protein HI1409 (H. influenzae strain Rd KW20, 
P44183, 0.0) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039532.1, 2e-48) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00042225.1, 5e-48) 
Hypothetical protein XF1571 XF1676 (prophages XfP3 and XfP4, 
A82664, 5e-48) 
Hypothetical protein (S. flexneri 2a strain 301, AAN42305.1, e-43) 
Probable bacteriophage protein STY1048 (S. enterica serovar 
typhimurium strain CT18, AG0621, e-43) 
Phage-related protein (X. fastidiosa strain Temecula1, 
AAO28846.1, 3e-41) 
Hypothetical protein (Mesorhizobium loti, BAB53655.1, e-38) 
Hypothetical protein Lin1731 (L. innocua strain Clip11262, 
AB1649, 4e-20) 
orf33 23679 26081 800 89.6 9.49 
Head 
protein 
TraN-related protein HI1407 (H. influenzae strain Rd KW20, 
B64122, e-109) 
Plasmid-related protein (X. fastidiosa strain Temecula1, 
AAO28843.1, 2e-34) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041695.1, 4e-34) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039531.1, 7e-33) 
Plasmid-related protein XF1574 XF1679 (prophages XfP3 and 
XfP4, E82650, 4e-32) 
Minor head protein (Enterococcus faecalis strain v583, 
AAO81248.1, e-15) 
orf34 25361 24462 299 34.3 9.88  
Hypothetical protein MJ0314 (Methanococcus jannaschii, 
NP_247287.1, 2e-06) 
orf35 25723 25391 110 11.8 4.35   
* Isoelectric point 
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf36 26713 27825 370 40.3 4.97  
Hypothetical protein HI1405 (H. influenzae strain Rd KW20, 
AAC23055.1, e-171) 
Hypothetical protein (M. loti, NP_108196.1, 8e-23) 
Hypothetical protein XF1575 XF1680 (prophages XfP3 and XfP4, 
F82650, 3e-22) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039530.1, 5e-22) 
Phage-related protein (X. fastidiosa strain Temecula1, 
AAO28842.1, e-21) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041694.1, e-21) 
Hypothetical protein (N. aromaticivorans, ZP_00096131.1, 6e-21) 
Probable bacteriophage protein STY1050 (S. enterica serovar 
typhimurium strain CT18, AI0621 , 2e-18) 
Putative bacteriophage protein (S. flexneri 2a strain 301, 
AAN42303.1, 6e-18) 
orf37 27839 28288 149 15.3 5.39   
orf38 28300 29214 304 33.2 7.03  
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041692.1, 4e-11) 
Hypothetical protein XF1577 XF1682 (prophages XfP3 and XfP4, 
H82650, 7e-11) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00038226.1, e-10) 
Phage-related protein (X. fastidiosa strain Temecula1, 
AAO28840.1, e-10) 
orf39 29225 29584 119 12.9 5.32  
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00038228.1, e-15) 
Hypothetical protein (X. fastidiosa strain Temecula1, AAO28838.1, e-15) 
Hypothetical protein XF1579 XF1684 (prophages XfP3 and XfP4, 
A82665, 2e-14) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041690, 4e-14) 
* Isoelectric point 
 
 
 
 
 
 
 
 39 
Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf40 29585 30031 148 16.6 9.49  
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041689.1, 5e-13) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039526.1, e-11) 
Phage-related protein (X. fastidiosa strain Temecula1, 
NP_779188.1, 7e-11) 
Hypothetical protein XF1580 XF1685 (prophages XfP3 and XfP4, 
C82651, 7e-11) 
orf41 30028 30399 123 13.9 9.43  
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041688.1, e-19) 
Hypothetical protein (X. fastidiosa strain Temecula1, AAO28836.1, 8e-19) 
Hypothetical protein XF1581 XF1686 (prophages XfP3 and XfP4, 
Q9P9T2, e-17) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039525.1, 4e-15) 
orf42 30185 30826 213 23.8 9.04  
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041687.1, e-18) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039524.1, e-16) 
Hypothetical protein (X. fastidiosa strain Temecula1, AAO28835.1, 7e-12) 
Hypothetical protein XF1582 XF1687 (prophages XfP3 and XfP4, 
E82651, 9e-12) 
orf43 30831 32339 502 54.5 5.72  
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039523.1, e-127) 
Phage-related protein (X. fastidiosa strain Temecula1, 
AAO28834.1, e-126) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041686.1, e-125) 
Hypothetical protein XF1583 XF1688 (prophages XfP3 and XfP4, 
F82651, e-123) 
Putative phage protein STY2029 (S. enterica serovar typhimurium 
strain CT18,AI0622, 4e-42) 
Hypothetical protein (Magnetospirillum magnetotacticum, 
ZP_00049744.1, 3e-36) 
* Isoelectric point 
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf44 32389 32820 143 15.7 5.58  
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041684.1, 2e-46) 
Hypothetical protein XF1584 XF1689 (prophages XfP3 and XfP4, 
F82665, 9e-46) 
Phage-related protein (X. fastidiosa strain Temecula1, 
AAO29040.1, e-45) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041331.1, 2e-42) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039522.1, 7e-41) 
orf45 32820 333239 139 15.3 6.17  
Hypothetical protein (X. fastidiosa strain Temecula1, NP_779390.1, 2e-20) 
Hypothetical protein XF1585 XF1690 (prophages XfP3 and XfP4, 
H82651, 5e-20) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041683.1, 2e-19) 
orf46 33390 35498 702 76.6 4.67 
Tail length 
tape 
measure 
protein 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039519.1, 2e-51) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041329.1, 3e-51) 
Phage-related protein (X. fastidiosa strain Temecula1, 
AAO28831.1, 4e-51) 
Hypothetical protein XF1587 XF1692 (prophages XfP3 and XfP4, 
B82652, e-49) 
Probable phage protein STY1061 (S. enterica serovar typhimurium 
strain CT18,  AD0623,  2e-11) 
Phage protein similar to tail length tape measure protein  (Clostridium  tetani  
strain  E88, NP_781744.1, 8e-09) 
orf47 34735 34133 200 21.5 8.67   
orf48 35502 36269 255 27.2 9.21  
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00038456.1, 2e-38) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041679.1, 6e-38) 
Hypothetical protein XF1591 (prophage XfP3, B82661, e-37) 
Phage-related protein (X. fastidiosa strain Temecula1, 
NP_779179.1, 4e-37) 
Probable phage protein STY1062 (S. enterica serovar typhimurium 
strain CT18, AE0623, 2e-06) 
* Isoelectric point 
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf49 36280 36594 104 11.9 4.97  
Hypothetical protein XF1628 (X. fastidiosa strain 9a5c, C82648, 2e-20) 
Hypothetical protein (X. fastidiosa strain Temecula1, NP_779178.1, 2e-18) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00038457.1, 8e-10) 
orf50 36881 37735 284 31.7 9.29  
Hypothetical protein XF1593 (prophage XfP3, D82661, 4e-78) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039058.1, 6e-77) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00042047.1, e-76) 
Phage-related protein (X. fastidiosa strain Temecula1, NP_779384.1, e-76) 
Hypothetical protein (M. magnetotacticum, ZP_00051100.1, e-20) 
Probable phage protein STY1064 (S. enterica serovar typhimurium 
strain CT18, AG0623, 3e-16) 
orf51 37732 38376 214 22.5 5.38 
Baseplate 
 protein 
Hypothetical protein XF1594 (prophage XfP3, E82661, 7e-33) 
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041677.1, 2e-32) 
Phage-related protein (X. fastidiosa strain Temecula1, NP_779176.1, 2e-32) 
Probable phage protein STY2019 (S. enterica serovar typhimurium 
strain CT18, AH0732, 4e-32) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039057.1, 5e-31) 
Hypothetical protein (M. magnetotacticum, ZP_00051101.1, 6e-17) 
Orf16 similar to V gene of P2 : baseplate (phage phi-CTX, 
BAA36243.1, 3e-06) 
orf52 38195 37776 139 14.5 9.47   
orf53 38373 38732 119 14 5.09  
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041676.1, 5e-27) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00038460.1, e-26) 
phage-related protein (X. fastidiosa strain Temecula1, AAO28824.1, 7e-26) 
Hypothetical protein XF1701 (prophage XfP4, F82648, 9e-26) 
Probable phage protein STY2019 (S. enterica serovar typhimurium 
strain CT18, AD0624, 4e-12) 
* Isoelectric point 
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Table 2. Continued. 
Gene 
Start 
position 
Stop  
position 
size  
(aa) 
Molecular 
mass 
(kDa) 
pI* 
Potential 
function 
(gene name) 
Significant matches 
(source, accession number, blastp e-value) 
orf54 38763 39905 380 42.4 5.03  
Hypothetical protein (X. fastidiosa strain Ann-1, ZP_00041674.1, 2e-97) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00038461.1, 6e-97) 
Phage-related protein (X. fastidiosa strain Temecula1, AAO29028.1, 2e-96) 
Hypothetical protein XF1704 (prophage XfP4, A82649, 5e-96) 
Probable phage protein STY2016 (S. enterica serovar typhimurium 
strain CT18, AE0732, 7e-35) 
Hypothetical protein (M. magnetotacticum, ZP_00050433.1, e-17) 
Hypothetical protein homolog Lin1710 (L. innocua strain Clip11262, 
AE1646, e-17) 
Hypothetical protein (Leptospira interrogans serovar lai strain 56601, 
NP_711243.1, 2e-17) 
Hypothetical protein (phage HF2, NP_542578.1, 4e-08) 
Hypothetical protein (phage Bcep781, NP_705659.1, 6e-08) 
orf55 39905 40486 193 22.1 9.59  
Hypothetical protein XF1705 (prophage XfP4, B82649, e-32) 
Hypothetical protein (X. fastidiosa strain Dixon, ZP_00039052.1, 2e-32) 
Phage-related protein (X. fastidiosa strain Temecula1, NP_779171.1, 7e-32) 
Hypothetical protein (X. fastidiosa strain Ann-1, NP_00041673.1, e-31) 
Probable phage protein STY1071 (S. enterica serovar typhimurium 
CT18, AF0624, 3e-12) 
Hypothetical protein HI1404 (H. influenzae strain Rd KW20, P44179, 5e-08) 
orf56 40497 41981 494 55.8 6.08 
Tail fiber  
protein 
Hypothetical protein HI1403 (H. influenzae strain Rd KW20, P44178, e-07) 
Similar to P2 tail fiber protein H (phage 186, AAC34164.1, 2e-04) 
orf57 41972 42592 206 23.5 5.44 
Tail fiber  
assembly 
protein 
Hypothetical protein NMA1328 (Neisseria meningitidis strain Z2491, 
H81901, 4e-17) 
Hypothetical protein NMB1119 (N. meningitidis strain MC58, 
A81120, e-16) 
Hypothetical protein (S. flexneri 2a strain 301, AAN41969.1, 5e-05) 
Tail fibre assembly protein P37 (phage SfV, AAL89429.1, 2e-04) 
* Isoelectric point 
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Similarities of the AaΦ23 potential ORFs to other sequences present in databases and 
functional assignments. The 57 potential genes and the corresponding protein sequences 
were compared to the Genbank and Swissprot databases. Characteristics of the gene products 
and the significant homologies are detailed below and are also listed in Table 2. Twelve 
ORFs (2, 6, 7, 11, 12, 18, 25, 26, 35, 37, 47 and 52) may be specific for AaΦ23 as no 
homology to other sequences could be found (Table 2). When analysing putative gene 
functions, an “early region” and a “late region” can be defined on the AaΦ23 genome (Figure 
1). Genes located in the early region (from nucleotide 1 to 17621) code for proteins involved 
in recombination, replication, and modification of the phage DNA. The region between 
nucleotide 18939 and 43033 represent the “late genes” region coding for the lytic system, 
DNA packaging and structural proteins. The same genetic organization has also been 
observed in other bacteriophages such as lambda, P22, L and LP-7 (Campbell 1994). 
 
Early region  
AaΦ23 integrase. It is likely that ORF1 may represent the integrase of phage AaΦ23. In fact 
it shows significant homologies to other phage integrase sequences (Table 2). The alignment 
of the AaΦ23 ORF1 with the integrase amino-acid sequences of these bacteriophages 
illustrates the observed homologies (Figure 2). Additionally, the Interproscan software 
identified a domain conserved among phage integrases from amino acid 145 to 324 (PFAM 
accession number PF00589, e-value of 1.7e-38). Thus, this enzyme may be a new member of 
the large family of integrase/recombinases (Nunes-Düby et al. 1998) which catalyses the site-
specific integration and excision of the AaΦ23 genome into and out of the host chromosome. 
As for phage lambda, the putative AaΦ23 integrase gene is located in a cluster of genes 
transcribed leftwards on the genetic map, i.e. in the opposite orientation to the majority of the 
phage genes (Figure 1). No gene coding for an excisionase has been identified on the 
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genome. This situation is also encountered in Streptococcus pneumoniae phage MM1 
(Obregon et al. 2003), Listeria monocytogenes phage A118 (Loessner et al. 2000) and 
Pseudomonas aeruginosa phage D3 (Kropinski 2000). 
 
Identification of the attP and attB integration sites of AaΦ23. Results of the SPCRs are 
shown on Figure 3. By sequencing of the SPCRs products, a 49 bp-long direct repeat was 
identified at the junction of prophage and bacterial DNA in the strain ZIB1023. Moreover, 
this repeat was found in the chromosome of the non lysogenic strains ZIB1001 and ZIB1015 
and was also evident as a single copy on the AaΦ23 DNA sequence. When strain ZIB1001 
was lysogenized to result in ZIB1515, the prophage was flanked by direct copies of the 
repeat, this representing the att site (Figure 4). Bio-informatics analysis revealed also a single 
copy of this repeat in the genome of HK1651 and Haemophilus influenzae Rd strain KW20. 
In AaΦ23 the att site is located 19 bp downstream from the putative integrase gene. The 
location of attP close and upstream to the integrase gene seems to be usual (Shimizu-Kadota 
et al. 2000, Auvray et al. 1999, van Mellaert et al. 1998). Similarly, the size of 49 bp that is 
rather long for an att site is not unusual (Shimizu-Kadota et al. 2000, Auvray et al. 1999, van 
Mellaert et al. 1998). We showed that the attB homologous sequence found in the genome of 
H. influenzae strain Rd KW20 is located at 111 nucleotides downstream from the ORF 
HI0274 coding for the glutamyl-tRNA synthetase (data not shown, Fleishmann and Venter 
1995). Identically, in the genome of HK1651, this sequence is located 109 nucleotides 
downstream from an ORF that present homologies with the ORF HI0274 of H. influenzae 
strain Rd KW20. Location of attB sequences at the 3’ end or even overlapping a tRNA gene 
has been frequently described (Auvray et al. 1999, McShan et al. 1997, Hauser and Scocca 
1992). 
 45 
             10        20        30        40        50        60 
                           |         |         |         |         |         | 
Int(DLP12)        -----MSLFRRNEIWYASYSLPGGKRIKESLGTKDKRQAQELHDKRKAELWRVEKLGDLP 
Int(APSE-1)       -----MSIFKRGKIWYGSYTTPCGKRIKESLGTEDKKQAQELHDKRRAELWRIAKLDDFP 
Int(ST64T)        -----MSLFRRGETWYASFTLPNGKRFKQSLGTKDKRQATELHDKLKAEAWRVSKLGETP 
Int(P22)          -----MSLFRRGETWYASFTLPNGKRFKQSLGTKDKRQATELHDKLKAEAWRVSKLGETP 
Int(SfV)          -----MSLFRRGEIWYASFTLPNGKRFKQSLGTKDKRQATELHDKLKAEAWRVSKLGEIP 
ORF1(AaΦ23)       MSRQIISLKKRGEIWHYSFTSPNGERVRRSARTSDKNQAQQLASKEYNECWRVFKLGERP 
 
                          70        80        90       100       110       120 
                           |         |         |         |         |         | 
Int(DLP12)        DVTFEEACLRWLEEKADKKSLDSDKSRIEFWLEHFEGIRLKDISEAKIYSAVSRMHNRKT 
Int(APSE-1)       NVTFDEACLRWIEEKANKKSLDDDKGRLGFWLLYFSGTRLKDMTEAKIYSAISKMKNRQE 
Int(ST64T)        DMTFEEACVRWLEEKAHKKSLDDDKSRIGFWLQHFAGMQLKDITETKIYSAIQKMTNRRH 
Int(P22)          DMTFEGACVRWLEEKAHKKSLDDDKSRIGFWLQHFAGMQLKDITETKIYSAIQKITNRRH 
Int(SfV)          DITFEEACVRWLEEKAHQKSLDDDKSRIGFWLQHFAGMQLRDITESKIYSAIQKMTNRRH 
ORF1(AaΦ23)       NYSWQEAVVQWLDEKPKRK-QDRNMLYGLVWLDKYLGDKKLNEIDRTLIKFIQYEKAKEG 
 
                         130       140       150       160       170       180 
                           |         |         |         |         |         | 
Int(DLP12)        KEIWKQKVQAAIRKGKELPVYEPKPVSTQTKAKHLAMIKAILRAAERDWKWLEKAPVIKI 
Int(APSE-1)       QLRWKSRVNSAKRKGIEIPAYQAKEVSIATKAKHLALLKSMMKSAERDWKWIEKSPVIKV 
Int(ST64T)        EENWKLMDEACRKNGKQPPVFKPKPAALATKATHLSFIKALLRAAEREWKMLDKAPIIKV 
Int(P22)          EENWKLMDEACRKNGKQPPVFKPKPAAVATKATHLSFIKALLRAAEREWKMLDKAPIIKV 
Int(SfV)          EENWRLRAEACRKKGKPVPEYTPKPASVATKATHLSFIKALLRAAEREWKMLDKAPIIKV 
ORF1(AaΦ23)       -------------------------VKARTINAVLQQIRVILRAAV-EWDWLDKCPAIKF 
 
                         190       200       210       220       230       240 
                           |         |         |         |         |         | 
Int(DLP12)        PAVRNKRVRWLEKEEAKRLIDECPEPLKSVVKFALATGLRKSNIINLEWQQIDMQRRVAW 
Int(APSE-1)       PSAREKRIRWLEPDEAERLINECPEPLRSTVEFALATGLRRSNIINLAWSQIDMQRKVAW 
Int(ST64T)        PQPKNKRIRWLEPHEAKRLIDECPEPLKSVVEFALSTGLRRSNIINLEWQQIDMQRKVAW 
Int(P22)          PQPKNKRIRWLEPHEAKRLIDECQEPLKSVVEFALSTGLRRSNIINLEWQQIDMQRKVAW 
Int(SfV)          PQPKNKRIRWLEPHEAQRLIDECPEPLKSVVEFALATGLRRSNIINLEWQQIDMQRRVAW 
ORF1(AaΦ23)       LPEPKRRVRWLTQHEEIRLIEELPEHLKPIVQFAILTGLRMSNITQLKWSQIDLSKRQAW 
 
                         250       260       270       280       290       300 
                           |         |         |         |         |         | 
Int(DLP12)        VNPEESKSNRAIGVALNDTACKVLRDQIGKHHKWVFVHTKAAKRADGTSTPAVRKMRIDS 
Int(APSE-1)       IEPENSKSGKAIGVALNDTACCILTRQLGNHQKWVFVHTMSAKRSDGSQTNSIRKMRVDS 
Int(ST64T)        IHPEQSKSNQAIGVALNDTACRVLKKQIGNHHKWVFVYKESSTKPDGTKSPVVRKMRYDA 
Int(P22)          IHPEQSKSNHAIGVALNDTACRVLKKQIGNHHKWVFVYKESSTKPDGTKSPVVRKMRYDA 
Int(SfV)          INPEESKSNRAIGVALNDTACRVLKKQIGNHHRWVFVYKESCTKPDGTKAPTVREMRYDA 
ORF1(AaΦ23)       INSEQSKTGNSIGVPLNDKAIEVIVSQFGKHKENVFTYKG-------------KPVRIAN 
 
                         310       320       330       340       350       360 
                           |         |         |         |         |         | 
Int(DLP12)        KTSWLSACRRAGIEDFRFHDLRHTWASWLIQSGVPLSVLQEMGGWESIEMVRRYAHLAPN 
Int(APSE-1)       NTAWRAALKRAGIENFRFHDLRHTWASWLIQSGVPLSVLQEMGGWESVEMVRRYAHLASN 
Int(ST64T)        NTAWRSALKRAGIEDFRFHDLRHTWASWLVQAGVPISVLQEMGGWESIEMVRRYAHLAPN 
Int(P22)          NTAWRAALKRAGIEDFRFHDLRHTWASWLVQAGVPISVLQEMGGWESIEMVRRYAHLAPN 
Int(SfV)          NTAWKAALRRAGIDDFRFHDLRHTWASWLGQAGVPLSVLQEMGGWESIEMVRRYAHLAPN 
ORF1(AaΦ23)       TKAFRAALQRAGIKDFRFHDLRHTWATRHIMSGTPLYVLQELGGWSKSDTVRKYAHLSVE 
 
                         370       380       390 
                           |         |         | 
Int(DLP12)        HLTEHARKIDDIFG-------DNVPNMSHSEIMEDIKKA 
Int(APSE-1)       HLTEHAKQIDGVFDRFNRKISNHVPNLSHLKILKS---- 
Int(ST64T)        HLTEHARQIDSIFG-------TSVPNMSHSKNKEGTNNT 
Int(P22)          HLTEHARQIDSIFG-------TSVPNMSHSKNKEGTNNT 
Int(SfV)          HLTEHARQIDSILN-------PSVPNSSQSKNKEGTNDV 
ORF1(AaΦ23)       HLQNHANNVQLFAT-------K-LAQTQRGKNLINN--- 
 
Figure 2. Alignment of AaΦ23 ORF1 with the amino acid sequences of several other bacteriophages Int. Identical residues 
are in red. The domain matching to the protein family PF00589 is underlined. Int accession numbers : AAC73638 (DLP12); 
NP_050999 (APSE-1); AAL15478 (ST64T); NP_059584 (P22); AAB72135 (SfV). 
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DNA 
Ladder 
Primer 
SPCR1 
Primer 
SPCR2 
Primer 
SPCR3 
Primer 
SPCR4 
21226 bp 
5148 bp 
3530 bp 
 
 
2027bp 
1584 bp 
1375bp 
 
947 bp 
 
831 bp 
Figure 3. PCR products of the semi-random PCRs performed with 
 
the primers SPCR1, 2, 3, and 4, respectively.   
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>attL of A. actinomycetemcomitans strain ZIB1023
TAGCTCAGTTGGGAGAGCGCTTGAATGGCATTCAAGAGGTCGTCGGTTCGATCCCGATTATCTCCACCAAATTTTATAGCTTTATCAATTAGTTAGTTATTGATA
                                                                                             *  N  N  I
>attR of A. actinomycetemcomitans strain ZIB1023
TGATTTATGTATAGGCTTTCAAATATGGCATTCAAGAGGTCGTCGGTTCGATCCCGATTATCTCCACCAAATTCCAAAATCCTATCAATAAAAATTGATAGGATT
>attP of bacteriophage Aa!23
TGATTTATGTATAGGCTTTCAAATATGGCATTCAAGAGGTCGTCGGTTCGATCCCGATTATCTCCACCAAATTTTATAGCTTTATCAATTAGTTAGTTATTGATA
                                                                                             *  N  N  I
>attB of A. actinomycetemcomitans strain HK1651
TAGCTCAGTTGGGAGAGCGCTTGAATGGCATTCAAGAGGTCGTCGGTTCGATCCCGATTATCTCCACCAAATTCCAAAATCCTATCAATAAAAATTGATAGGATT
>attL of A. actinomycetemcomitans strain ZIB1515
TAGCTCAGTTGGGAGAGCGCTTGAATGGCATTCAAGAGGTCGTCGGTTCGATCCCGATTATCTCCACCAAATTTTATAGCTTTATCAATTAGTTAGTTATTGATA
                                                                                             *  N  N  I
>attR of A. actinomycetemcomitans strain ZIB1515
TGATTTATGTATAGGCTTTCAAATATGGCATTCAAGAGGTCGTCGGTTCGATCCCGATTATCTCCACCAAATTCCAAAATCCTATCAATAAAAATTGATAGGATT
>attB of A. actinomycetemcomitans strain ZIB1015
TAGCTCAGTTGGGAGAGCGCTTGAATGGCATTCAAGAGGTCGTCGGTTCGATCCCGATTATCTCCACCAAATTCCAAAATCCTATCAATAAAAATTGATAGGATT
>attB of A. actinomycetemcomitans strain ZIB1001
TAGCTCAGTTGGGAGAGCGCTTGAATGGCATTCAAGAGGTCGTCGGTTCGATCCCGATTATCTCCACCAAATTCCAAAATCCTATCAATAAAAATTGATAGGATT
>attB of H. influenzae strain Rd KW20
TAGCTCAGTTGGGAGAGCGCTTGAATGGCATTCAAGAGGTCGTCGGTTCGATCCCGATTATCTCCACCAAATTAATAAAGCAAGGTAAAGCACCTTGCTGTTTTA
Figure 4. attP, attL, attR, and attB sites on the bacteriophage Aa!23 genome and on several bacterial genomes. The att core sequence is boxed. The C-terminal end of the putative
integrase is underlined. * represent the stop codon of the integrase gene.
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Region between genes int and c1. The region located between nucleotide 1115 and 9405 
contains eleven putative ORFs, 10 of them being transcribed in the same orientation as the 
putative integrase gene (Figure 1). Five ORFs (2, 6, 7, 11 and 12) seem to be specific for 
AaΦ23, as they do not share any homologies with other sequences present in databases 
(Table 2). Five ORFs (3, 4, 5, 9 and 10) have homologies with hypothetical proteins of A. 
actinomycetemcomitans strain HK1651 while ORF8 may have a homologue in several other 
bacterial species (Table 2). 
 
Gene expression regulation proteins, lysogeny control. Five ORFs coding for putative 
proteins involved in regulatory functions have been identified on the AaΦ23 genome. The 
potential ORF13 present strong homologies to the repressor protein CI of the Siphoviridae 
lambda-like phage phi-80, which infects E. coli (Eguchi et al. 1988) and several other 
probable transcriptional regulators found in different bacterial species (Table 2). Moreover, 
this protein contains a helix-turn-helix motif from amino acid 12 to 66 (PFAM accession 
number PF013081, e-value of 1.1e-08) which is a signature of DNA binding proteins. In 
bacteriophage lambda this repressor protein is responsible for maintaining the prophage in the 
lysogenic state (Ptashne 1992). The product of orf14 is a protein of 68 amino acids that 
shares significant homologies with unknown proteins (Table 2) and weak homologies to the 
transcription regulatory protein Cro of several bacteriophages and bacteria (Table 2). 
Identification of potential cI and Cro homologues on the AaΦ23 genome may be an 
indication that AaΦ23 uses the same lysogeny control system as phage lambda. In bacteria 
lysogenic for lambda the expression of lytic genes is repressed by binding of cI to the OL and 
OR operators (Ptashne 1992). OR is located between the cI and cro genes and is composed of 
three oligonuleotide sites of two-fold symmetry separated by short spacers. As for the 
Shigella flexneri phage SfV (Allison et al. 2002), three regions containing inverted repeats 
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are evident in the cI and cro intergenic region of AaΦ23 (Figure 5). These sequences are 
named IR1, IR2 and IR3 and may be analogues of the three sequences (OR1, OR2, OR3) that 
compose the OR operator of phage lambda. Bio-informatics analysis revealed two putative 
promoter sequences in this region (Figure 5). The first, from nucleotide 10054 to 10104 may 
correspond to the promoter for repressor maintenance (PRM) and the second, from nucleotide 
10099 to 10147 could represent the promoter PR’, both of them being described in lambda 
(Ptashne 1992). Orf24 codes for a putative anti-repressor belonging to the protein family of 
Ant which is expressed in several phages and has been extensively characterized in P22 
(Sauer et al. 1983). Ant could play a role in the regulation of lysogeny. It prevents the 
prophage P22 cII repressor protein from binding to its operators and also inhibits the action 
of other prophage repressor proteins (Sauer et al. 1983). The deduced gene product of orf16 
may be a second anti-repressor protein similar to the one named antB in E. coli O157:H7 
(Table 2). It shows significant sequence similarities to the gene HI1422 of H. influenzae 
strain Rd KW20 and to putative anti-repressors from different phages (Table 2). The gene 
product of orf23 shares significant homologies with a probable anti-termination protein Q of 
Yersinia pestis strain KIM (Table 2). In bacteriophage lambda, this rho-dependent 
termination protein allows RNA-polymerase to over-ride the termination signal downstream 
of promoter PR’ so that the lytic and structural genes can be transcribed (Petrov et al. 1981). 
Finally, no homologies to other regulatory proteins like cII and cIII repressors and anti-
termination protein N have been identified on the AaΦ23 genome. 
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10001 CTCTTGTTTTGTTGCGTCATAAGTTCGGCAAGTCTGCTCGCAAGTGTCGT
         K  N  Q  Q  T  M  L  E  A  L  R  S  A  L  T  T
10051 CATATAAACTCCCATTTCTACTGTAGGTAGAAGATACATAAATAAAATAG
       M
 
10101 TTGATTCAATTCTATTTTTAGTAGTAGAATTATGCTACTTTAAATAGATA
10151 TGAGGGGTTAAAATGCTACCAATCGAAAAAGCTTACAAAATCGTGGGTGG
                   M  L  P  I  E  K  A  Y  K  I  V  G  G
 
10201 GATTTCGGCTATGGCTCGTCATTTCAATCTTACTCCTTGGGCAGTTTCCA
        I  S  A  M  A  R  H  F  N  L  T  P  W  A  V  S
 
Figure 5. Inverted repeats IR1, IR2 and IR3 in the cI and cro intergenic region. Regions of inverted
repeats are boxed in green, blue and red respectively for IR3, IR2 and IR1. Inverted repeats are
italicized within boxes. Putative promoters PRM and PR’ are underlined.
CI
Cro
IR3
IR2 IR1
PRM
PR’
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DNA replication. The DNA replication machinery of AaΦ23 seems to be closely related to 
that of the lambdoid bacteriophages. ORF17 is similar to the protein GP18 of phage P22 
which is related to the replication protein O of phage lambda (Swissprot accession number 
P03688). This protein is necessary for the initiation of the bi-directional DNA replication. 
Protein O interacts with the lambda origin of replication and protein P (Zylicz et al. 1984). 
Indeed, ORF19 present strong homologies to a replication P protein found in several 
bacteriophages and bacteria (Table 2). By its DNA helicase activity, this enzyme plays an 
essential role in a variety of processes such as DNA replication, repair, recombination and 
transcription (Waksman et al. 2000). 
 
DNA recombination. ORFs 21 and 22 show homologies, respectively, to the ninG and ninB 
proteins expressed by several different phages (Table 2). In lambda, these two genes are 
known as orf (ninB) and rap (ninG), two recombination genes located in the ninR region. A 
recent study showed that orf and rap participate in Red recombination, the primary pathway 
operating when wild-type lambda grows lytically in rec+ cells (Tarkowski et al. 2002). 
Additional experiments are needed to determine if AaΦ23 induces a similar pathway when it 
grows lytically in A. actinomycetemcomitans.  
 
Methylase. DNA methylases participate in regulatory events of DNA replication, methyl-
directed mismatch repair and transposition (Marinus 1996). These enzymes are associated 
with bacterial DNA restriction-modification systems whose are responsible for the 
degradation of foreign DNA such as conjugative plasmids and transposons (Meselson et al. 
1972) or bacteriophage DNA (Bickle and Krüger 1993). It has been speculated that some 
bacteriophages express their own DNA adenine methylases in order to overcome this 
bacterial protection. DNA adenine methylases play also a role in regulating bacterial 
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virulence (Heithoff et al. 1999). One putative DNA adenine methylase (ORF20) is possibly 
expressed by AaΦ23 (Table 2). This ORF contains a D/N-P-P-Y/F motif, from amino acid 61 
to 64, which is conserved in this family of enzymes (PFAM accession number PF02086, 
Timinskas et al. 1995). An A. actinomycetemcomitans DNA adenine methylase has been 
shown to be active in vivo (Eberhard et al. 2001). Nevertheless, the role of DNA adenine 
methylases in the regulation of A. actinomycetemcomitans virulence genes remains to be 
determined. 
 
Late region.  
Lytic enzyme complex. The lysis system of AaΦ23 seems to be composed of, at least, two 
different components. Orf28 probably codes for the lytic enzyme of AaΦ23 which degrades 
the A. actinomycetemcomitans peptidoglycan barrier in order to allow the liberation of viral 
progeny into the extracellular media as this protein shares strong homologies with several 
lytic enzyme found in bacteriophages and bacteria (Table 2). This putative ORF matched also 
with amino acid sequences of members of the glycoside hydrolase family 19 (PFAM 
accession number PF00182, e-value of 1.2e-2). Additionally, ORF28 shows significant 
homologies with a putative chitinase (Table 2). The previous observation that some chitinases 
and several lysozymes from animals and bacteriophages present structural similarities (Holm 
and Sander 1994), support the possibility that the gene product of orf28 represent the phage 
AaΦ23 lytic enzyme. ORF29 present significant homologies to the putative Rz lytic protein 
expressed by the S. flexneri bacteriophage SfV (Table 2). In many phages of Gram-negative 
hosts, Rz together with another short protein called Rz1, plays a role as an auxiliary lysis 
protein that is thought to interact with the outer membrane or with its links to the cell wall 
(Young et al. 2000). Thus, although no holin and Rz1 genes could be identified, we can 
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speculate that AaΦ23 uses the same lysis strategy as decribed for many double-stranded 
DNA phages (Young et al. 2000).  
 
DNA packaging. Two genes (orf30 and orf31) are possibly coding for the two components 
of the terminase enzyme (Table 2). This holoenzyme is required for packaging of the phage 
genomic DNA into the empty capsid shells (Catalano 2000). In AaΦ23, the phage DNA has 
been shown to have random terminal redundancy of 1.6 kb that are circularly permuted (Willi 
and Meyer 1998) and it may therefore be packaged by the headfull mechanism. Thus, the 
AaΦ23 terminase complex may cut concatemeric DNA molecules, resulting from rolling 
circle replication, at a unique pac site to start the first round of packaging. Taking into 
consideration the 1.6 kb terminal redundancy, about 104% of the genomic DNA molecule is 
packaged into phage heads on subsequent rounds of packaging.  
 
Structural components of the virion particle. The gene products of orfs 33, 46, 56, 57 and 
51 seem to be, respectively, elements of the head, tail, tail fibers (ORFs 56 and 57) and 
baseplate of the AaΦ23phage particle (Table 2). ORF33 contains also a conserved domain, 
from amino-acid 156 to 256, found in members of a family representing putative minor phage 
head proteins (PFAM accession number PF04233, e-value of 2e-21).  
 
Similarities with the genome sequence of the A. actinomycetemcomitans strain HK1651. 
Southern-blot experiments revealed two very distincts patterns when the ZIB1023 and 
HK1651 genomic DNA was hybridized with the AaΦ23 DNA (Figure 6). Analysis of the 
phage genomic sequence revealed two segments of strong homologies over 8.7% of the 
AaΦ23 genome (average of 97% homologies over 3,795 bps) with the A. 
actinomycetemcomitans strain HK1651 genomic sequence (Figure 1). On the protein level, 
 54 
six AaΦ23 ORFs share significant homologies with ORFs of the A. actinomycetemcomitans 
strain HK1651 genome (Table 2). The very short extent of homologies between the A. 
actinomycetemcomitans strain HK1651 and the AaΦ23 genome and the very different 
patterns observed in southern-blot experiments suggest that strains HK1651 and ZIB1023 do 
not carry the same prophage. Therefore it was not surprising that we were not able to induce 
phages production from A. actinomycetemcomitans strain HK1651 by mitomycin C 
treatment. This DNA of limited homology to AaΦ23 could represent remnants of an AaΦ23-
related prophage. However, the presence of an unrelated prophage with limited homologies to 
AaΦ23 in the genome of the strain HK1651 cannot be excluded. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ZIB1001 DNA 
Ladder 
HK1651 ZIB1023 
21226 bp 
564 bp 
831 bp 
947 bp 
5148 bp 
3530 bp 
1584 bp 
Figure 6. Southern-blot hybridization of genomic DNA of strains ZIB1001,  
 
ZIB1023 and HK1651 digested with EcoRI using phage AaΦ23 DNA as the probe. 
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Similarities to the plant pathogenic bacterium Xylella fastidiosa. One interesting 
observation is that 40% of the overall AaΦ23 ORFs (23/57) share homologies with 
hypothetical proteins from three strains of the plant pathogen X. fastidiosa (Table 2). In X. 
fastidiosa strain 9a5c, about 7% of the entire genome is related to double-stranded DNA 
phage sequences, mostly from the lambda group (Simpson and Setubal 2000). Four putative 
prophages, XfP1, XfP2, XfP3 and XfP4, were identified on this genome (Simpson and 
Setubal 2000). XfP3 and XfP4 are exactly similar over 14,317 bp. Homologies of thirteen 
AaΦ23 ORFs with the X. fastidiosa strain 9a5c genome can be found in this duplicated 
region (Table 2). In addition, three AaΦ23 ORFs (48, 50 and 51) share homologies with 
ORFs only found in the XfP3 prophage and three other (53, 54 and 55) are closely related to 
ORFs only present on the XfP4 prophage. These observations suggest that AaΦ23, XfP3 and 
XfP4 could have had a common ancestor. Moreover, three AaΦ23 ORFs (8, 14 and 49) 
showed similarities to X. fastidiosa strain 9a5c ORFs that are not carried by prophages (Table 
2). Nevertheless, the X. fastidiosa homologue of AaΦ23 ORF8 is annotated as being a phage-
related hypothetical protein (Table 2) and ORF14 may correspond to the Cro repressor 
protein in AaΦ23 (Table 2). ORF49 is the only one that present homologies with a putative 
ORF of the X. fastidiosa bacterium but not with a phage-related protein (Table 2). Finally, the 
putative integrase of AaΦ23 has homologies with a hypothetical protein found in the X. 
fastidiosa strains Ann-1 and Dixon but is not represented on the X. fastidiosa strain 9a5c 
genome (Table 2). 
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CHAPTER II 
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Characterization of the DNA adenine 
methylase of the Actinobacillus 
actinomycetemcomitans bacteriophage 
AaΦ23 
 
ABSTRACT 
 
In the following study we reported cloning of the DNA adenine methyltransferase gene (dam) 
of the Actinobacillus actinomycetemcomitans bacteriophage AaΦ23, experimental 
characterization of its product (M.AaΦ23Dam), and comparison with DNA adenine 
methylases from other phages. Morever, a pairwise alignment of M.AaΦ23Dam and the 
DNA adenine methylase of A. actinomycetemcomitans (M.AacDam) is proposed. Based on 
this alignment, comparative analysis of these enzymes and their close homologs revealed, 
despite an overall sequence divergence, conserved essential cofactor-binding and catalytic 
residues. However, significant differences were found in the cofactor-binding domain and 
regions that are thought to contact the target DNA sequence are missing in M.AaΦ23Dam. 
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INTRODUCTION 
 
Bacterial DNA methyltransferases are associated with bacterial DNA restriction-
modification systems to protect against phage infections (Bickle and Krüger 1993). 
Moreover, they participate in regulatory events of DNA replication, repair and transcription 
(Marinus 1996). On the basis of different chemical reactions, DNA methyltransferases can be 
divided into three different groups, generating N6-methyladenine (m6A), N4-methylcytosine 
(m4C), and C5-methylcytosine (m5C). While nine protein sequence motifs are conserved 
among members of these groups, a region of essentially higher variability was also identified 
(Malone et al. 1995). Motifs I-III and X have been shown to be part of the AdoMet-binding 
subdomain, motifs IV-VIII were assigned to the active-site subdomain, and the variable 
region was recognized as a separate target-recognizing domain (Dryden 1999, Schlukebier et 
al. 1998, Kumar et al. 1998, Malone et al. 1995). 
DNA adenine methylases catalyse the transfer of a methyl group from S-adenosyl-L-
methionine (AdoMet) to the N-6 position of the adenine in a specific DNA sequence 
(Marinus and Morris 1973). A recent nomenclature for restriction enzymes and DNA 
methylases has been published (Roberts et al. 2003). DNA adenine methylases are classified 
within the Type I (as product of hsdM gene), Type II or Type III (as product of mod gene) 
restriction-modification systems and are divided in three distinct groups (α, β and γ) in 
respect to the sequential order of motifs of the protein sequence (Malone et al. 1995). 
DNA adenine methylase regulation of gene expression was shown in E. coli for trpR 
(Peterson et al. 1985), Tn10 transposase (Roberts et al. 1985), dnaA (Braun and Wright 
1986). Moreover, DNA adenine methylases were reported to control the expression of a 
number of virulence genes (Low et al. 2001). The expression of the Escherichia coli 
pyelonephritis-associated pilus (pap) genes, which encode pili that are required for infection 
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of the urinary tract, is reversibly switch between the unexpressed and the expressed states by 
a methylation-sensitive process termed phase variation (van der Woude et al. 1996, Braaten 
et al. 1994). Dam- mutants of Salmonella enterica serovar typhimurium are dramatically 
reduced in their virulence as compared to the wild-type strain (Heithoff et al. 1999). DNA 
adenine methylase overproduction was found to attenuate the virulence of Yersinia 
pseudotiberculosis and Vibrio cholerae leading to, in Yersinia, a fully protective immune 
response in vaccinated hosts (Julio et al. 2001). Additionally, DNA adenine methylation 
exerted by bacterial enzymes plays an important role during development of many phages. In 
Mu it is involved in the regulation of mom genes expression (Hattman 1999) and in P1 it is 
essential for cleavage of the pac site, which initiates the packaging of phage DNA during the 
lytic cycle (Sternberg and Coulby 1990). Nevertheless, several phages encode their own 
DNA adenine methylase. Despite evidence that some phage DNA is modified by virus-
encoded methylases in order to evade host restriction (Günthert and Trautner 1984), the 
precise functions of these enzymes are still unclear as no systematic knock-out mutagenesis 
study has been performed for phages DAM to assess to what degree does their functions 
overlap with that of the host enzyme. 
Recently the GATC-specific DNA adenine methylase of bacteriophages HP1 was 
characterized (M.HP1Dam, Piekarowicz and Bujnicki 1999) and compared to its H. 
influenzae homologue (M.HinDam, Bujnicki et al. 2001). Despite overall divergence, both 
enzymes share the common fold and essential cofactor-binding and catalytic residues. 
However, significant differences in the cofactor-binding pocket have been identified. 
Moreover, loops involved in contact with the target DNA sequence are missing in the phage 
enzyme. 
Cloning, sequence analysis and heterologous expression of the GATC-specific DNA adenine 
methylase of A. actinomycetemcomitans (M.AacDam, Eberhardt et al. 2001)), a Gram-
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negative facultative anaerobe that has been strongly implicated in the etiology of localized 
juvenile periodontitis (Zambon 1985), opened the path for studies on the potential regulatory 
impact of DNA methylation on gene regulation and virulence in this organism. In this 
bacterial species, lysogeny is widespread (Iff et al. 1997, Willi et al. 1997a, Loftus and 
Delisle 1995, Sandmeier et al. 1995, Willi et al. 1993). It has previously been shown that one 
representative of a family of A. actinomycetemcomitans bacteriophages, the bacteriophage 
AaΦ23, carries a gene coding for a putative DAM (M.AaΦ23Dam, Chapter I). To further 
characterize DAM occurring in A. actinomycetemcomitans we cloned and expressed the gene 
coding for M.AaΦ23Dam in an E. coli dam- host, compared the amino acid sequence of the 
corresponding gene product with known DNA adenine methylase sequences of other 
bacteriophages and aligned it with the recently characterized M.AacDam. 
 
MATERIALS AND METHODS 
 
Bacterial strains, media and culture conditions. A. actinomycetemcomitans ZIB1023 is the 
natural strain lysogenic for AaΦ23. ZIB1001, ZIB1015 are non lysogenic A. 
actinomycetemcomitans strains. ZIB1504 and ZIB1515 are respectively strains ZIB1015 and 
ZIB1001 that were experimentally lysogenized with AaΦ23 and A. actinomycetemcomitans 
HK1651 is a clinical isolate, the genome of which has been sequenced (Advanced Center for 
Genome Technology, Oklahoma’s University), obtained from Mogens Kilian (University of 
Aarhus, Denmark). These strains were grown in Todd Hewitt Broth 3% (w/v) (THB, BD 
Biosciences, Allschwil, Switzerland) at 37°C in air and 10% CO2. E. coli GM48 (dam-, 
Palmer and Marinus 1994) electro-competent cells were used as hosts for recombinant 
plasmids. GM48 cells were grown in Luria-Bertani medium (Sambrook et al. 1989) at 37°C 
in air. 
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Purification of the AaΦ23 phage DNA. Phage DNA of AaΦ23 was prepared according to 
the procedure previously described (Willi et al. 1993). Briefly, after mitomycin C (1 µg/ml) 
induction of bacteriophage from a log-phase growing culture of A. actinomycetemcomitans 
strain ZIB1023, phage particles were recovered by a polyethylene glycol 8000 precipitation 
and centrifugations. Phage genomic DNA was extracted by phenol/chloroform and 
precipitated by ethanol. All reagents were purchased from Sigma (Buchs, Swizerland). 
 
CTTTTAACTC AACTGAATCG TGGGCTTGAA AGTCGCTCAG ATAAACGACC  
               damL 
AATGCCAAGT GACAGCCGTG ATACAGGACA AATTGAACAA GAGTGTGATT  
 
ACTGGTTGGG ACTTTATAAA GAATCCGTTT ACAACGAAAA CGCCGACCCA  
 
AGTTTGACAG AAATTATCGT GCGATTAAAT CGCCATGGTG GAACCGGTAA  
 
AGCCTATTGC GATCAGAAAT TTGGTGCAAT GTTTGAATGC GATCAATTAG  
 
ACGCAGAAAG ACGATCGCAA ATCGGCAAAA AAGAAACAAA ACAAGAAACA  
 
ACAAGATTTT CAAAAGGGAA TAAGGGATTT TAATCATGGC AGACTTTGAC  
 
AAAGATACCT ATCCAACATC ATTTTCACTA TTTAACCCGA TTCATGCTGA  
 
ATTTGGCTTC ACGATTGATG GCGCCGCACT GCCCCACAAC GCAAAACTTG  
 
AGCGATATGT AACGCCTGAA ATGGATTACT TAACTTACCC GATACAAAAC  
 
GAGCGTATTT TCATCAACCC GCCATTTAGT GATCCGTTAA GTTTTATCAA  
 
ACGTTCCGTC GAACTGTTTG AAAATCACAA CTGCTTAGTG GCTATGTTGT  
 
TGCCGGTTGA TATAAGCACA AAATGGTTTG CTTTGGTGGC TGAAAAAGCA  
 
ACGGAAATTA GATTTATCAT CGGTGGCCGC GTGAAATTTT TAAATCCTGC  
 
AACGGGCAAG TACACAGATG TTTGCCGTGG GAATATGTTT GCAATCTTTA  
 
ATCCGGCTCA CAAAGGCATG AGCCAAGTTA TCCGCAATGT TCATATCAAC  
 
ACCTTTAAAA ATTTGGAGTG GCGGCAATGA 
 
      damR 
 
Figure 7. Nucleotide sequence of the previously identified gene coding for the putative M.AaΦ23Dam. 
Start and stop codons are boxed. Putative M.AaΦ23Dam promoter is underlined. Hybridization sites of the primers damL 
and damR are represented in bold and underlined with arrows pointing in 5’ to 3’ orientation. 
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PCR conditions and PCR product purification. The genomic DNA of AaΦ23 was directly 
used as template in the PCR reactions. Primers were designed on the basis of the previously 
established complete genomic sequence of the bacteriophage AaΦ23 (Chapter I and Figure 
7). Primers damL (5’-GCGAATTCCTCAGATAAACGACCAATGCCA-3’) and damR (5’-
GCGAATTCTCATTGCCGCCACTCCAAATTT-3’) were chosen in order to amplify a 
fragment containing the gene coding for the putative M.Aa.Φ23Dam together with 300 bp 
upstream region to include the putative promoter sequence (Figure 7) identified with the 
promoter predictor software (http://www.fruitfly.org/seq_tools/promoter.html). Denaturation, 
primer annealing and extension were done respectively at 94°C, 57°C and 72°C for 35 cycles 
in a GeneAmp® PCR system 9700 apparatus (Perkin Elmer, Langen, Germany). PCR 
products were purified using the QIAquick® PCR Purification kit (Qiagen, Basel, 
Switzerland). Oligonucleotides were purchased from Microsynth GmbH (Balgach, 
Switzerland). 
 
Cloning of the PCR fragment and sequencing of the recombinant vector. The PCR 
fragments obtained and the cloning vector pUC19 (Stratagene, Zürich, Switzerland) were 
digested with EcoRI and purified. After treatment of the vector with shrimp alkaline 
phosphatase, ligation of the PCR fragment into the vector was conducted 16 h at 16 °C in a 
total volume of 10 µl containing 1U of T4 DNA ligase. The ligation mixture was 
electroporated in E.coli GM48 electro-competent cells and recombinant clones were isolated 
on ampicillin-containing agar plates. Plasmids were recovered from selected clones and were 
first screened for insert by EcoRI digestion and gel electrophoresis. Plasmids carrying an 
EcoRI insert of the same size as the PCR fragment obtained with primers damL and damR 
were sequenced using the Big-dye technology (Perkin Elmer). Sequencing reactions were 
analysed on an ABI PRISM 377 automated DNA sequencer (Perkin Elmer). Enzymes were 
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purchased from Roche Diagostics AG (Rotkreuz, Switzerland) and other reagents were 
obtained from Sigma 
 
Isolation of bacterial genomic DNA and methylation-sensitive restriction digestion. 
Genomic DNA of several A. actinomycetemsomitans strains and of E. coli strain GM48 was 
isolated with the QIAamp® DNA Mini Kit (Qiagen) following recommendations of the 
manufacturer. Methylation-sensitive restriction digestions were performed using Sau3AI and 
MboI (Bioconcept, Allschwil, Switzerland). Digestions were conducted overnight at 37°C 
and analysed on a 1% low-melting agarose gel (Seakem® LE Agarose, Bioconcept). 
 
Sequence analysis. The amino acid sequence of the putative M.AaΦ23Dam was compared to 
the Swissprot database using the blastp software under ORF finder 
(http://www.ncbi.nlm.nih.gov/gorf/orfig.cgi). Alignment of M.AaΦ23Dam with its homologs 
was done using ClustalW (http://www.ebi.ac.uk/clustalw) and modified manually, taking into 
account previously predicted conserved secondary structural elements. 
 
RESULTS AND DISCUSSION 
 
In silico identification of M.AaΦ23Dam.  
Comparison of M.AaΦ23Dam with known DNA adenine methylases. Table 3 lists other 
phage DNA adenine methylases showing significant homologies to M.AaΦ23Dam. An 
alignment of M.AaΦ23Dam with it phage homologs is represented (Figure 8). The 
M.AaΦ23Dam is closely related to the M.HP1Dam and M.HP2Dam (Table 3). We therefore 
tentatively applied the molecular model of M.HP1Dam (Bujnicki et al. 2001) to 
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M.AaΦ23Dam (Figure 8). The order of the conserved motifs identified on M.AaΦ23Dam 
indicates that it belongs to the γ group (Malone et al. 1995). 
Based on structural superposition of molecular models, M.HinDam and M.HP1Dam were 
previously pairwise aligned and compared (Bujnicki et al. 2001). M.AacDam (Eberhard et al. 
2001) and M.HinDam (Bujnicki et al. 2001) have extended amino acid sequence homologies, 
especially in the conserved motifs (Figure 9). The order of the conserved motifs identified on 
M.AacDam indicates that it belongs to the α group (Malone et al. 1995). As the molecular 
model of M.HinDam (Bujnicki et al. 2001) might be applicable to M.AacDam, we aligned 
and compared M.AaΦ23Dam with M.AacDam (Figure 10).  
 
 
Table 3. Bacteriophage proteins showing significant homologies with M.AaΦ23Dam. 
Protein name Phage name blastp e-value Accession number 
M.HP2Dam Phage HP2 5e-20 NP_536818 
M.HP1Dam Phage HP1 5e-20 P51715 
M.CP-933VDam Coliphage CP-933V 3e-15 NP_288678 
M.Lahn3Dam Coliphage Lahn3 4e-15 CAC95062 
M.Nil2Dam Coliphage Nil2 4e-15 CAC95095 
M.HK97Dam Coliphage HK97 4e-15 NP_037744 
M.VT2-SaDam Coliphage VT2-Sa 5e-15 NP_050531 
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        10        20        30        40        50        60 
                      |         |         |         |         |         | 
M.HP2Dam     -MNKSNTKKSDKDLWATPWWVFHYAEQYFNIKFDLDTCAMEHNTKVKNFITPEQNTLTAD 
M.HP1Dam     MMTKSNTKKSDKDLWATPWWVFHYAEQYFNIKFDLDTCAMEHNTKVKNFITPEQNTLTAD 
M.Nil2Dam    MTIKSNTPAHDKDCWQTPLWLFDALDIEFG--FWLDSAASDKNALCAHWLTEADDALNSE 
M.VT2-SaDam  MTIKSNTPAHDKDCWQTPLWLFDALDIEFG--FWLDSAASDKNALCAHWLTEADDALNSE 
M.HK97Dam    MTIKSNTPAHDKDCWQTPLWLFDALDIEFG--FWLDSAASDKNALCAHWLTEADDALNSE 
M.Lahn3Dam   MTIKSNTPAHDKDCWQTPLWLFDALDIEFG--FWLDSAASDKNALCAHWLTEADDALNSE 
M.CP-933VDam MTIKSNTPAHDKDCWQTPLWLFDALDIEFG--FWLDSAASDKNAXCAHWLTEADDALNSE 
M.AaΦ23Dam   ------MADFDKDTYPTSFSLFNPIHAEFG--FTIDGAALPHNAKLERYVTPEMDYLTYP 
        Motif I   Motif II   Motif III 
 
                     70        80        90       100       110       120 
                      |         |         |         |         |         | 
M.HP2Dam     WQGR-YCWMNPPYSNPLPFVLRAISQSVLHNKTVVMLLNVDGSTKWFDMCVRNAKEIVYI 
M.HP1Dam     WQGR-YCWMNPPYSNPLPFVLRAISQSVLHNKTVVMLLNVDGSTKWFDMCVRNAKEIVYI 
M.Nil2Dam    WISHGAIWNNPPYSNIRPWVEKAAEQCIQQRQTVVMLVPEDMSVGWFSKALESVDEVRII 
M.VT2-SaDam  WVSHGAIWNNPPYSNIRPWVEKAAEQCIQQRQTVVMLVPEDMSVGWFSKALESVDEVRII 
M.HK97Dam    WISHGAIWNNPPYSNIRPWVEKAAEQCIQQRQTVVMLVPEDMSVGWFSKALESVDEVRII 
M.Lahn3Dam   WISHGAIWNNPPYSNIRPWVEKAAEQCIQQRQTVVMLVPEDMSVGWFSKTLESVDEVRII 
M.CP-933VDam WISHGAIWNNPPYSNIRPWVEKAAEQCIQQRQTVVMLVPEDMSVGWFSKALESVDEVRII 
M.AaΦ23Dam   IQNE-RIFINPPFSDPLSFIKRSVELFENHNCLVAMLLPVDISTKWFALVAEKATEIRFI 
      Motif IV   Motif V       Motif VI  Motif VII 
 
                    130      140       150        160       170 
                      |        |         |          |         | 
M.HP2Dam     TNSRIPFINNETGEETDQNNKPQMLVLFEPKAPYGSLKSSYVSLHEMKEKEMLQ--- 
M.HP1Dam     TNSRIPFINNETGEETDQNNKPQMLVLFEPKAPYGSLKSSYVSLHEMKEKGMLQ--- 
M.Nil2Dam    TDGRINFIEPSTGLEKKGNSKGSMLLIWRPFISPRRMFTTVSKAALMAIGQGVRRAA 
M.VT2-SaDam  TDGRINFIEPSTGLEKKGNSKGSMLLIWRPFISPRRMFTTVSKAALMAIGQGVRRAA 
M.HK97Dam    TDGRINFIEPSTGLEKKGNSKGSMLLIWRPFISPRRMFTTVSKSALMAIGQGVRRAA 
M.Lahn3Dam   TDGRINFIEPSTGLEKKGNSKGSMLLIWRPFISPRRMFTIVSKAALMAIGQGVRRAA 
M.CP-933VDam TDGRINFIEPSTGLEKKGNSKGSMLLIWRPFISPRRMFTTVSKAALMAIGLGVRRAA 
M.AaΦ23Dam   IGGRVKFLNPATGKYTD-VCRGNMFAIFNPAHKGMSQVIRNVHINTFKNLEWRQ--- 
    Motif VIII      Motif VIII’ 
 
Figure 8. Sequence alignment of M.AaΦ23Dam with its phage homologues. Similar residues are coloured in red. Conserved 
motifs are underlined and numbered according to Malone et al. (1995). The conserved motif D/N-P-P-Y/F among protein 
family PF02086 is represented in italic within motif IV.  
 
Comparison of regions interacting with the S-adenosyl-L-methionine. Motifs I-III and X 
are involved in the binding of the AdoMet (Labahn et al. 1994). A pronounced difference 
between M.AaΦ23Dam and M.AacDam is observed in the N terminal region before motif I 
(Figure 10). The region in M.AaΦ23Dam is shorter and lacks motif X. This motif, which is 
perfectly similar between M.AacDam and M.HinDam, has been shown to be part of the 
binding pocket for the methionine moiety of AdoMet in M.HhaIDam (Cheng et al. 1993). 
While in M.AacDam the G-loop of motif I includes the conserved tripeptide FxG (FVG47) of 
DNA adenine methylases of group α, M.AaΦ23 harboures an unusual YPT11 tripeptide. The 
G-loop binds to the methionine moiety of the AdoMet. Replacement of the FV46 dipeptide of 
M.AacDam motif I by the YP10 dipeptide in M.AaΦ23Dam motif may not modify dramatical 
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the AdoMet binding pocket as both dipeptides have the same spatial bulk. This FxG motif 
may be conserved only among bacterial enzymes as the M.HP1Dam shows also a very 
different motif (WAT17). One rule of this motif I is respected in M.AaΦ23Dam and 
M.AacDam as the residue at position 2 amino acids upstream from the FxG consensus pattern 
is, respectively, the D7 and the E43. This residue is thought to interact with the G-loop and 
therefore adding stereochemical constraints in the binding pocket. 
                      10       20       30        40        50       60 
                       |        |        |         |         |        | 
M.AacDam      MPEPAKPATP--AKSRPFLKWAGGKYRLMDEINRLLPKRKQCLVEPFVGAGAVFLNSNFK 
M.HinDam      MLRPKKQSLKPKLKHRPFLKWAGGKFRLTDEINKAFPNKKNCLIEPFVGAGAVFLNSNFE 
          Motif X            Motif I 
 
                      70       80        90      100       110      120 
                       |        |         |        |         |        | 
M.AacDam      RYILADINPDLINLFNIVKLDVERYIQACKPIFFHPEANTEIYYYGKRKEFNQSTDVFQR 
M.HinDam      RYILADINPDLINLFNIVKXNVDGYIEDCKPIFFADDANTPDYYYAKRRQFNASTEPFER 
   Motif II 
  
                     130      140       150       160      170       180 
                       |        |         |         |        |         | 
M.AacDam      AVLFLYLNRFGFNGLCRYNSKNEFNVPFGDYKTHYFPEEELRFFAAKAQSAVFICADFQQ 
M.HinDam      SIIFLYLNRFGFNGLCRYNSKNEFNVPFGAYKTHYFPEDELRYFAHKAQSAVFLCCDFQK 
       TRD       Motif III 
 
                     190      200       210      220       230      240 
                       |        |         |        |         |        | 
M.AacDam      TFEMADENSVIYCDPPYAPLSQDSNFTNYAGNEFSIGHQRDLANLAKHTMEQRNIQVLIS 
M.HinDam      TFEFADKDSVIYCDPPYAPLQQETNFTGYAGNEFGLAQQRALADLAKSIQKEKQISILIS 
    Motif IV      Motif V     Motif VI 
 
                     250      260       270      280 
                       |        |         |        | 
M.AacDam      NHDTPFTREIYQGAKIRRLKVQRSISQAPHKRIKVRELIAMFKQGK 
M.HinDam      NHDTKFTREIYNGAKFKRVKVQRSISQNPEKRVKVKELIAIFGARK 
        Motif VII  Motif VIII     Motif VIII’ 
 
Figure 9. Sequence alignment of the M.AacDam and M.HinDam. Similar residues are coloured in red. Conserved motifs are 
underlined and numbered according to Malone et al. (1995). The target-recognizing domain (TRD) is underlined with a 
dashed line. The conserved motif D/N-P-P-Y/F conserved among protein family PF02086 is represented in italic within 
motif IV. 
 
M.AacDam       MPEPAKPATP--AKSRPFLKWAGGKYRLMDEINRLLPKRKQCLVEPFVGAGAVFLNSNFK 
M.AaΦ23Dam                                          MADFDKDTYPTSFSLFNPIHAE 
       Motif X        Motif I 
 
M.AacDam     RYILADINPDLINLF(92)AQSAVFICADFQQTFEMADENSVIYCDPPYAP(19)QRDLANL 
M.AaΦ23Dam   FG--FTIDGAALPHN----AKLERYV-TPEMDYLTYPIQNERIFINPPFSD----PLSFIKR 
    Motif II  Motif III      Motif IV      Motif V 
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M.AacDam      AKHTMEQRNIQVLISNHDTPFTREIYQGAKIRRLKVQRSISQAPH----------KRIKVR 
M.AaΦ23Dam    SVELFENHNCLVAMLLPVD-ISTKWFALVAEKATEIRFIIGGRVKFLNPATGKYTDVCRGN 
         Motif VI   Motif VII 
 
M.AacDam      ELIAMFKQGK 
M.AaΦ23Dam    MFAIFNPAHK 
        Motif VIII’ 
 
Figure 10. Sequence alignment of the M.AacDam and M.AaΦ23Dam derived from sequence comparison of M.AacDam 
with M.HinDam and M.AaΦ23Dam with M.HP1Dam. Structural conserved motifs are underlined and numbered according 
to Malone et al. (1995). The conserved motif D/N-P-P-Y/F, conserved among the protein family PF02086, is represented in 
italic within motif IV. 
 
In motif II, a D is conserved among the group α and is also found in M.HP1Dam (D36). This 
charged residue interacts with the ribose hydroxyl of the AdoMet. In M.AaΦ23Dam it is 
replaced by a polar T26 that may also interact with the hydroxyl group of the AdoMet by 
hydrogen bonds. The following residue is usually a bulky hydrophobic residue. It is also the 
case in M.AacDam and M.AaΦ23Dam as a non-polar I is found at this position in both 
enzymes. This residue is making van der Waals contacts with the AdoMet adenine (Malone 
et al. 1995). 
 
Comparison of residues involved in the calalytic activity and target recognition. Motifs 
IV to VIII are thought to be part of the active domain of DNA adenine methylases. The 
conserved D/N-P-P-Y/F motif encountered in motif IV of DAM that represents the active site 
of the enzyme is also present in the putative motif IV of M.AaΦ23Dam (NPPF64). 
Nevertheless, M.AaΦ23Dam, as well as the EcoRI associated DNA adenine methylase, 
represent exception of the γ group which members usually have a NPPY motif (Malone et al. 
1995). Putative motif VII of M.AaΦ23Dam begins with a relatively hydrophobic residue 
(N82) and ends with two hydrophobic residues (LL89) in place of the usual hydrophobic 
residues SN. In motif VIII, the F196 of M.TaqIDam that is suggested to make favourable van 
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der waals contacts to the target DNA adenine (Schluckebier et al. 1995), is replaced by an 
unusual Q in M.HinDam and M.AacDam. In view of the alignment, in M.AaΦ23Dam the 
corresponding amino acid may be the R109 of motif VII. Similarly, an R has been described at 
this position for the DNA adenine methylase of E. coli (Malone et al. 1995). Nevertheless an 
F, which might also be a good candidate for the residue that contacts the DNA adenine, is 
present at position 110 on M.AaΦ23Dam. Moreover, this F110 is replaced in M.HP1Dam by 
the Y118 residue. The role of the F196 of M.TaqIDam is possibly played by a corresponding Y 
residue in motif VIII of several DNA adenine methylases of the α group (Malone et al. 
1995). The observation that the TRD is lacking in all bacteriophages DNA adenine 
methylases studied so far, is also made for M.AaΦ23Dam. Moreover, the loop between 
motifs IV and V, which makes contact with the target DNA, is also missing in M.AaΦ23Dam 
as for M.HP1Dam and others (Figure 8). Finally, the putative DNA binding loop described 
for M.HP1Dam and represented by the insertion between motifs VII and VIII’ (Bujnicki et al. 
2001) is also present on M.AaΦ23Dam but not in M.AacDam (Figure 8 and 10).  
 
PCR amplification and cloning of the ΑaΦ23  dam gene. By using the primers damL and 
damR on the genome of phage AaΦ23, a fragment of approximately 800 bp in size was 
amplified (Figure 11). The size of this fragment is in good agreement with the size of the 
gene coding for M.AaΦ23Dam manually determined on the previously established nucleotide 
sequence (Figure 7). This 800 bp PCR product was successfully cloned into the EcoRI site of 
the cloning vector pUC19 to yield recombinant plasmid pUC19::M.AaΦ23dam (Figure 11). 
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In vivo activity of M.AaΦ23Dam in E. coli GM48 dam- cells. In order to find out if 
M.AaΦ23dam is expressed in E. coli GM48, bacterial DNA was isolated from both GM48 
and GM48(pUC19::M.AaΦ23dam) and digested with the restriction enzymes MboI and 
Sau3AI. MboI recognizes and cleaves only the non-methylated palindromic genomic GATC 
DNA sequences, while the Sau3AI isoschizomer is not sensible to DNA adenine methylation. 
As shown on Figure 12 the genomic DNA of wild-type E.coli GM48 is restricted by both 
enzymes. This confirms that in E. coli GM48 the adenine residue of genomic GATC 
sequences is not methylated. In contrast, The genomic DNA of 
GM48(pUC19::M.AaΦ23dam) is not cleaved by MboI. This proves that the genomic DNA 
has been methylated by the M.AaΦ23Dam activity. Moreover, results suggest that the 
putative promoter of M.AaΦ23Dam is functional in E.coli. 
M.AaΦ23Dam may be classified in the Type IIP group of DNA methyltransferase as it 
recognize and methylate a palindromic DNA sequence (Roberts and Xu 2003). Nevertheless, 
no genes potentially coding for a cognate endonuclease associated with M.AaΦ23Dam has 
been identified on the genome of the AaΦ23 bacteriophage (Chapter I).  
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pUC19 
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pUC19 
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21226 bp 
 
5148 bp 
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564 bp 
Figure 11. Cloning of the damL/damR PCR product in the vector pUC19 
 
digested with EcoRI.  
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DNA adenine methylase activity in six clinical isolates of A. actinomycetemcomitans. 
Three non-lysogenic and three strains lysogenic for AaΦ23 were tested. While MboI was not 
able to cut the genomic DNA of the strains (Figure 13a), Sau3AI successfully restricted all of 
them (Figure 13b). These results are in agreement with the expression of a functional DNA 
adenine methylase that methylates the adenine residue of the genomic GATC of all tested 
strains. Moreover, bio-informatics analysis revealed that the genome of strain HK1651 
carries a dam gene similar to the one previously cloned (Eberhard et al. 2001). Thus, DNa 
adenine methylases may be widespread and conserved among A. actinomycetemcomitans. 
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Figure 12. Methylation sensitive digestion of genomic DNA of dam- E. coli 
 
GM48 and GM48(pUC19::AaΦ23Dam) cells. 
DNA 
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Figure 13b. Digestion of genomic DNA isolated from several A. actinomycetemcomitans with the  
 
methylation non-sensitive restriction enzyme Sau3AI.  
Figure 13a. Digestion of genomic DNA isolated from several A. actinomycetemcomitans with the  
 
methylation-sensitive restriction enzyme MboI.  
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CONCLUSIONS 
 
A functional DNA adenine methylase is encoded in the genome of AaΦ23. This enzyme 
show the same specificity as the DNA adenine methylases expressed by three non-lysogenic 
and three AaΦ23-lysogenized A. actinomycetemcomitans strains. The analysis presented here 
help to visualize similarities and differences between the M.AaΦ23Dam and its host 
counterparts. These informations might be very useful for designing futur experiments that 
could elucidate the roles played by M.AaΦ23Dam in the development of AaΦ23 and 
possibly in the virulence of A. actinomycetemcomitans. Nevertheless, one obstacle for latter 
study will be the lack of virulence tests adapted to A. actinomycetemcomitans. In lysogenic 
bacteria, not only the chromosomal encoded DNA adenine methylase might be expressed but 
also homologue enzymes encoded on prophages. Our study emphasizes that similarities and 
differences between the DNA adenine methylases of bacteria and phages may be crucial for 
designing new inhibitors. In fact, in bacterial cells lysogenized with a DNA adnine 
methylase-encoding phage, treatment with specific inhibitors of bacterial DNA adenine 
methylases might remain ineffective.  
 
Acknowledgements. We thank Thomas Bickle for the E. coli strain GM48. 
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The lytic enzyme  
of Actinobacillus actinomycetemcomitans 
bacteriophage AaΦ23 
Preliminary results 
 
INTRODUCTION 
 
Bacteriophages were, directly after their discovery, considered as very promising 
agents for antibacterial therapy. In fact, the large majority of these bacterial viruses is 
naturally able to lyse its host. However, due to the rapid emergence of phage resistance, this 
approach had little clinical significance. Recent studies showed that purified lysin was able to 
kill Streptococcus pneumoniae (Loeffler et al. 2001) and Bacillus anthracis (Schuch et al. 
2002) in vitro and eradicate a Streptococcus pyogenes infection in mice (Nelson et al. 2001).  
This approach has only been tested with Gram-positive microorganisms because they have no 
outer membrane and when the lytic enzyme is administrated from outside, it may be able to 
reach the peptidoglycan barrier without the help of an holin.  
In many double-stranded DNA phages of Gram-negative bacteria the lysis process is 
achieved by an enzymatic complex consisting of a lytic enzyme (encoded by the lys gene), a 
holin and accessory lytic proteins Rz and Rz1 (Young et al. 2000). The complete genome 
sequence sequence of phage AaΦ23 reveals a gene possibly coding for a lytic enzyme 
(orf28). No candidate gene coding for a holin was identified (Chapter I). We undertook the 
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cloning of the orf28 into an expression vector in the hope to be able to overexpress and purify 
the corresponding gene product for subsequently testing its activity.  
 
MATERIALS AND METHODS 
 
Bacterial strains, media, and culture conditions. A. actinomycetemcomitans ZIB1023 is 
the natural strain lysogenic for AaΦ23. This strain was grown in Todd Hewitt Broth 3% 
(w/v) (THB, BD Biosciences, Allschwil, Switzerland) at 37°C in air and 10% CO2. 
Escherichia coli XL1 Blue electro-competent cells (Stratagene, Zürich, Switzerland) were 
used as hosts for the recombinant plasmids and E. coli BL21 supercompetent cells (E. coli B 
F- ompT hsdS(rB-mB-) dcm+ TetR gal λ(DE3) endA Hte [pLysS CamR]) (Stratagene) were 
used as hosts for the recombinant expression vector. E. coli cells were grown in Luria-Bertani 
medium (Sambrook et al. 1989) at 37°C in air. 
 
Purification of the AaΦ23 phage DNA. Phage DNA of AaΦ23 was prepared according to 
the procedure previously described (Willi et al. 1993). Briefly, after mitomycin C (1 µg/ml) 
induction of bacteriophage of a log-phase growing culture of A. actinomycetemcomitans 
strain ZIB1023, phage particles were recovered by a polyethylene glycol 8000 precipitation 
and centrifugations. Phage genomic DNA was extracted by phenol/chloroform and 
precipitated by ethanol. All reagents were purchased from Sigma (Buchs, Swizerland). 
 
PCR amplification of the lys gene. PCR amplification of a fragment containing the lys gene 
was obtained using primers lysL (5’-CCGGAATTCATGTTTATCACACAA-3’) and lysR 
(5’-CCGGAATTCTCACCCCAATAAGTT-3’) and the phage AaΦ23 DNA as template. 
Denaturation, primer annealing and extension were done respectively at 94°C, 55°C and 
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72°C for 35 cycles in a GeneAmp®PCR system 9700 apparatus (Perkin Elmer, Langen, 
Germany). PCR product was purified using the QIAquick® PCR Purification kit (Qiagen, 
Basel, Switzerland). Oligonucleotides were purchased from Microsynth GmbH (Balgach, 
Switzerland). 
 
Cloning of the PCR fragment and sequencing of the recombinant cloning vector. The 
PCR fragment obtained and the cloning vector pBluescript II SK- (Stratagene) were digested 
with EcoRI and purified. After treatment of the vector with shrimp alkaline phosphatase, 
ligation of the PCR fragment into the vector was conducted 16 h at 16°C in a total volume of 
10 µl containing 1U of T4 DNA ligase. The ligation mixture was electroporated into E.coli 
XL1 Blue electro-competent cells and recombinant clones were isolated on ampicillin-
containing agar plates. Plasmids were recovered from selected clones and were first screened 
for insert by EcoRI digestion and gel electrophoresis. Plasmids carrying EcoRI fragments of 
the same size as the PCR fragment obtained with primers lysL and lysR 
(pBluescript::AaΦ23lys) were sequenced using the Big-dye technology (Perkin Elmer, 
Langen, Germany). Sequencing reactions were analysed on an ABI PRISM 377 automated 
DNA sequencer (Perkin Elmer). After digestion of the selected pBluescript::AaΦ23lys with 
EcoRI, the purified insert was subcloned into the expression vector pTYB1 (Bioconcept, 
Allschwil, Switzerland). Briefly, 1µg of pTYB1 was linearized with EcoRI during 8 h at 
37°C in the appropriate buffer. After purification and dephosphorylation with shrimp alkaline 
phosphatase, 50 ng of pTYB1 was ligated with excess of insert in a total volume of 10 µl 
containing 1U of T4 DNA ligase. Ligation mixtures were incubated for 16 h at 16°C. BL21 
cells were mixed with the ligation mixtures and heat-schock pulsed according to the 
recommendations of the manufacturer. Transformed cells were immediately diluted with 
prewarmed SOC medium (Sambrook et al. 1989) and incubated 1h at 37°C in air with 
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shaking. Finally, cells were plated on agar plates containing ampicillin (50 µg/ml). Enzymes 
were purchased from Roche Diagnostics AG and other reagents were obtained from Sigma. 
 
RESULTS AND DISCUSSIONS 
 
By using the primers lysL and lysR, a fragment of expected 600 bp in size was amplified 
(Figure 14). The PCR product was successfully cloned into the prokaryotic cloning vector 
pBluescript II SK- (Figure 14) but not in pTYB1. Sequencing of pBluescript::AaΦ23lys 
plasmids recovered from 20 selected clones showed that the lys gene was inserted always in 
the non-transcribed orientation. These results suggest that expression of the lys gene, even to 
background level, may be lethal for E. coli cells. Attempts, by using primers with different 
restriction sites, were made to force the lys gene to insert into the cloning and expression 
vectors in the transcribed orientation. No recombinant clones with both vectors were 
obtained. We thought that these observations could provide the first indirect evidence that 
orf28 gene may code for the lytic enzyme of AaΦ23. 
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Figure 14. Cloning of the lysL/lysR PCR products  
 
into the vector pBluescript II SK- digested with EcoRI. 
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The integration system  
of Actinobacillus actinomycetemcomitans 
bacteriophage AaΦ23. 
Preliminary results 
 
INTRODUCTION 
 
A. actinomycetemcomitans is a Gram-negative human periodontal pathogen (Zambon 
1985). A large portion of clinical isolates are lysogenized by morphologically and genetically 
related bacteriophages (Haubek et al. 1997, Iff et al. 1997, Willi et al. 1993). The 
bacteriophage AaΦ23 derived from A. actinomycetemcomitans strain ZIB1023 has a 43,033 
bp double-stranded genome (Chapter I). In the prophage state, AaΦ23 DNA is integrated in 
the host chromosome at a specific site. The attachment sites of the phage (attP) and the 
bacterial host (attB) have been identified (Chapter I) and suggest a site-specific 
recombination process (Campbell 1962). Several forms of site-specific recombination are 
well characterized in Gram-negative bacteria and the best-studied system is that of phage 
lambda (Landy 1989). The recombination process is catalysed by a phage-encoded integrase 
(Int). An putative int gene has been suggested to be present on the AaΦ23 genome (Chapter 
I). The gene product was proposed as a new member of the Int family of site-specific 
recombinases. Similarities and differences between members of this family have been 
extensively studied (Nunes-Düby et al. 1998). Based on these results, an analysis of the 
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AaΦ23 Int amino acid sequence is presented. In order to prove the function of the proposed 
Int, we constructed an integrative vector based on the integration elements of phage AaΦ23. 
 
MATERIALS AND METHODS 
 
Bacterial strains, media, and culture conditions. A. actinomycetemcomitans ZIB1023 is 
the natural strain lysogenic for AaΦ23. ZIB1001 is a non-lysogenic strain of A. 
actinomycetemcomitans. Both strains were grown in Todd Hewitt Broth 3% (w/v) (THB, BD 
Biosciences, Allschwil, Switzerland) at 37°C in air and 10% CO2. 
 
Purification of the AaΦ23 phage DNA. Phage DNA of AaΦ23 was prepared according to 
the procedure previously described (Willi et al. 1993). Briefly, after mitomycin C (1 µg/ml) 
induction of bacteriophage from a log-phase growing culture of A. actinomycetemcomitans 
strain ZIB1023, phage particles were recovered by a polyethylene glycol 8000 precipitation 
and centrifugations. Phage genomic DNA was extracted by phenol/chloroform and 
precipitated by ethanol. All reagents were purchased from Sigma (Buchs, Swizerland). 
 
PCR amplification of the integration region . PCR amplification of a fragment containing 
the int gene, its putative promoter (Pint) and the attP site was done using primers intL (5’-
GCGAATTCGTATCGCGTCATAAATGCCGTG-3’) and intR (5’-
GCGAATTCTGATTTCATTCAGCAGAAATCA-3’) and phage AaΦ23 DNA as the 
template. Denaturation, primer annealing and extension were done respectively at 94°C, 55°C 
and 72°C for 35 cycles in a GeneAmp® PCR system 9700 apparatus (Perkin Elmer, Langen; 
Germany). PCR product was purified using the QIAquick® PCR Purification Kit (Qiagen, 
Basel, Switzerland). 
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Cloning of the PCR fragment into pKT210. The PCR product and the broad host range 
cloning vector pKT210 (Bagdasarian et al. 1981) were digested with EcoRI and purified. 
After treatment of the vector with shrimp alkaline phosphatase, ligation of the PCR fragments 
into the vector was conducted 16 h at 16°C in a total volume of 10 µl containing 1U of T4 
DNA ligase. Enzymes were purchased from Roche Diagostics AG (Rotkreuz, Switzerland) 
and other reagents were obtained from Sigma (Buchs, Switzerland). 
 
Preparation of A. actinomycetemcomitans ZIB1001 electro-competent cells, 
electroporation with the ligation mixture, and selection of recombinant clones. Electro-
competent ZIB1001 cells were prepared according to Sreenivasan et al. (1991). Briefly, a 
single colony of A. actinomycetemcomitans ZIB1001 was cultived over-night in THB at 37°C 
in air and 10% CO2. Three additional 1:20 dilutions followed by over-night culture were 
done. The cell culture was then diluted 1:1 and incubated at 37°C in air and 10% CO2 till the 
OD600nm reached a value of 0.4. Cells were washed twice with half a volume of ice-cold 
buffer EPB (glycerol 15% (v/v), sucrose 272 mM, K2HPO4 2,43 mM, KH2PO4 0,57 mM). 
Finally, pelleted cells were resuspend in ice-cold EPB buffer and frozen at -70°C. 60 µl of 
electro-competent A. actinomycetemcomitans ZIB1001 cells were transformed by 
electroporation with the ligation mixture. Settings of the electro cell manipulator® were 
V=2.5 kV; R=186 Ω. Electroporated cells were immediately diluted in 1 ml of prewarmed 
THB and grown for 5H at 37°C in air and 10% CO2. Finally, cells were plated on blood-agar 
(BA) plates containing chloramphenicol (50 µg/ml). Antibiotic was purchased from Sigma. 
 
Sequence analysis. The amino acid sequence of the P22 and lambda Int were retrieved 
manually from NCBI (http://www.ncbi.nlm.nih.gov/) with their accession numbers. AaΦ23 
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Int and retrieved sequences were aligned with ClustalW (http://www.ebi.ac.uk/clustalw) and 
annotated manually according to Nunes-Düby et al. (1998). 
 
RESULTS AND DISCUSSION 
 
In silico identification of the AaΦ23 Int. The first interesting observation is that the AaΦ23 
ORF1 is closely related to the Int of several Podoviridae and a cryptic E. coli prophage 
(Table 2 of Chapter I). Homologies with Int found in Myoviridae such as P1, HP1 and HP2 
are still significant but weaker (data not shown). In order to find out conserved motifs and 
residues in M.AaΦ23 Orf, its amino acid sequences was aligned with the P22 and lambda Int 
(Figure 15 and 16). The conserved boxes I and II and additional patches I, II and III 
previously described (Nunes-Düby et al 1998) can be delimited on the AaΦ23 ORF1 amino 
acids sequence (Figures 15 and 16). 
The first observation is that the conserved tetrad RHRY described in all Int and which 
includes the active site tyrosine (Pargellis et al. 1998, Nunes-Düby et al. 1998, Abremski and 
Hoess 1992) is present in AaΦ23 ORF1 (R221H320R323Y355 on Figure 15). In boxes I and II, 
about 60% of the amino acid residues are identical among AaΦ23 Orf1 and its P22 
homologue (Figure 15). The pattern of conserved hydrophobic residues forming the core of 
the globular structure that was described for all members of the Int family (Kwon et al. 1997), 
is conserved in the AaΦ23 ORF1. Only three amino acids substitutions in this pattern are not 
favorable. Lambda Int residue Y (position 197 on Figure 16) is replaced by the acidic residue 
E (position 187 on Figure 16) in AaΦ23 ORF1. The residue T (position 291 on Figure 16) is 
replaced by the basic residue K (position 291 on Figure 16) and the residue corresponding to 
L (position 273 on Figure 16) is missing in AaΦ23 ORF1. Nevertheless the conservation of 
hydrophobic residues is 87%, meaning that the overall hydrophobic character of this pattern 
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is conserved. In patch I, the consensus LT-EEV--LL (Nunes-Düby et al. 1998) and is 
represented by the sequence LT-HEE--LI (Figures 15 and 16) on AaΦ23 ORF1. The second 
E residue in the LT-EEV--LL consensus is conserved (position 196 on Figure 15 and 185 on 
Figure 16). This residue is of particular importance as E169K mutated P2 Int are ineffective 
in recombination (Nunes-Düby et al. 1998).  
 
                      10        20        30        40        50       60 
                       |         |         |         |         |        | 
ORF1(AaΦ23)   MSRQIISLKKRGEIWHYSFTSPNGERVRRSARTSDKNQAQQLASKEYNECWRVFKLGERP 
Int(P22)      -----MSLFRRGETWYASFTLPNGKRFKQSLGTKDKRQATELHDKLKAEAWRVSKLGETP 
 
                      70        80        90      100       110       120 
                       |         |         |        |         |         | 
ORF1(AaΦ23)   NYSWQEAVVQWLDEKPKRK-QDRNMLYGLVWLDKYLGDKKLNEIDRTLI----------- 
Int(P22)      DMTFEGACVRWLEEKAHKKSLDDDKSRIGFWLQHFAG-MQLKDITETKIYSAIQKITNRR 
 
                     130       140       150      160       170       180 
                       |         |         |        |         |         | 
ORF1(AaΦ23)   -----KFIQYEKAKEG----------VKARTINAVLQQIRVILRAAV-EWDWLDKCPAIK 
Int(P22)      HEENWKLMDEACRKNGKQPPVFKPKPAAVATKATHLSFIKALLRAAEREWKMLDKAPIIK 
 
                     190       200       210       220      230       240 
                       |         |         |         |        |         | 
ORF1(AaΦ23)   FLPEPKRRVRWLTQHEEIRLIEELPEHLKPIVQFAILTGLRMSNITQLKWSQIDLSKRQA 
Int(P22)      VPQPKNKRIRWLEPHEAKRLIDECQEPLKSVVEFALSTGLRRSNIINLEWQQIDMQRKVA 
                          Patch I                     *  Box I 
 
                     250       260       270       280       290      300 
                       |         |         |         |         |        | 
ORF1(AaΦ23)   WINSEQSKTGNSIGVPLNDKAIEVIVSQFGKHKENVFTYKG---KP----------VRIA 
Int(P22)      WIHPEQSKSNHAIGVALNDTACRVLKKQIGNHHKWVFVYKESSTKPDGTKSPVVRKMRYD 
                     Patch II                  Patch III 
 
                     310       320       330       340      350       360 
                       |         |         |         |        |         | 
ORF1(AaΦ23)   NTKAFRAALQRAGIKDFRFHDLRHTWATRHIMSGTPLYVLQELGGWSKSDTVRKYAHLSV 
Int(P22)      ANTAWRAALKRAGIEDFRFHDLRHTWASWLVQAGVPISVLQEMGGWESIEMVRRYAHLAP 
                                 *  *       Box II                  * 
 
                     370       380       390 
                       |         |         | 
ORF1(AaΦ23)   EHLQNHANNVQ-LFATKLAQTQRGKN--LINN- 
Int(P22)      NHLTEHARQIDSIFGTSVPNMSHSKNKEGTNNT 
 
Figure 15. Alignment of AaΦ23 ORF1 with the amino acid sequence of P22 Int (accession number DAA00998). Identical 
residues are in red. The conserved domains are underlined and numbered according to Nunes-Düby et al. (1998). The highly 
conserved RHRY tetrad containing the active site tyrosine is indicated by asterisks.  
 
In patch II, a consensus (SKTG--I--P249 in AaΦ23 Int, Figure 16) is common for the AaΦ23 
ORF1 and lambda Int. The conserved K of this consensus is at one edge of the catalytic 
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pocket (Kwon et al. 1997). Substitution of the adjacent T in lambda Int (position 242 on 
Figure 16) provokes a decrease in recombination activity (Han et al. 1994). 
 
                       10        20        30        40       50        60 
                        |         |         |         |        |         | 
ORF1(AaΦ23)    MSRQIISLKKRGEIWHYSFTSPNGERVRRSARTSDKN----------QAQQLASKEYNEC 
Int(Lambda)    MGRRRS--HERRDLPPNLYIRNNGYYCYRDPRTGKEFGLGRDRRIAITEAIQANIELFSG 
 
                       70        80        90       100      110        120 
                        |         |         |         |        |          | 
ORF1(AaΦ23)    WRVFKLGERPNYSWQEAVVQWLDEKPKRKQDR--------NMLYGLVWLDKYLGDKKLNE 
Int(Lambda)    HKHKPLTARINSDNSVTLHSWLDRYEKILASRGIKQKTLINYMSKIKAIRRGLPDAPLED 
 
                      130       140       150       160       170       180 
                        |         |         |         |         |         | 
ORF1(AaΦ23)    IDRTLIKFIQYEKAKEGVKARTINAVLQQIRVILRAAVEWDWLDKCPAIKFLPEPKRRVR 
Int(Lambda)    ITTKEIAAMLNGYIDEGKAASAKLIRSTLSDAFREAIAEGHITTNHVAATRAAKSEVRRS 
 
                      190       200       210       220      230       240 
                        |         |         |         |        |         | 
ORF1(AaΦ23)    WLTQHEEIRLIEEL---PEHLKPIVQFAILTGLRMSNITQLKWSQIDLSKRQAWINSEQS 
Int(Lambda)    RLTADEYLKIYQAAESSPCWLRLAMELAVVTGQRVGDLCEMKWSDIVDG----YLYVEQS 
                  Patch I                       *  Lambda box I 
 
                      250       260       270      280       290       300 
                        |         |         |        |         |         | 
ORF1(AaΦ23)    KTGNSIGVPLNDKAIEVIVSQFGKH----KE----NVFTYKGKPVRIANTKAFRAALQRA 
Int(Lambda)    KTGVKIAIPTALH IDALGISMKETLDKCKEILGGETIIASTRREPLSSGTVSRYFMRAR 
        Patch II         Patch III 
 
                      310       320       330       340       350      360 
                        |         |         |         |         |        | 
ORF1(AaΦ23)    GIKDF-------RFHDLRHTWATRHIMSGTPLYVLQELGGWSKSDTVRK-YAHLSVEHLQ 
Int(Lambda)    KASGLSFEGDPPTFHELRSLSARLYEKQISDKFA-QHLLGHK-SDTMASQYRDDRGHANN 
                             *  *        Lambda box II           * 
                      370       380 
                        |         | 
ORF1(AaΦ23)    NVQLFATKLAQTQRGKNLINN 
Int(Lambda)    REWDKIEIK 
 
Figure 16. Alignment of AaΦ23 ORF1 with the amino acid sequence of the lambda Int (accession number P03700). 
Identical residues are in red. The conserved domains are underlined and numbered according to Nunes-Düby et al. (1998). 
The highly conserved RHRY tetrad containing the active site tyrosine is indicated by asterisks.  
 
Patch III is less conserved among Int but a consensus pattern (VF-YK) can be designed for 
AaΦ23 ORF1 and its P22 homologue (Figure 15). Patch III is thought to be important in 
stabilizating the native folds of the Int recombinases. After patch III, a stretch of 13 amino 
acids is missing is comparison with P22 Int and the region between Patch III and Box II 
comprises only 23 residues in AaΦ23 ORF1 (Figure 15). Nevertheless, AaΦ23 putative Int is 
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not unique for this characteristic as the same region in bacteriophage SF6 contains only 25 
residues (Nunes-Düby et al. 1998). One remarkable difference between AaΦ23 ORF1 and its 
P22 homologue is the deletion of 26 residues in the N terminal region of the protein (residues 
111 to 125 and 137 to 146, Figure 15). No functions for the corresponding residues in other 
Int have been reported, suggesting that this region is not essential. 
Identification of conserved Patchs, Boxes and key residues in the AaΦ23 ORF1 strongly 
suggests that the corresponding gene codes for the Int protein of AaΦ23.  
 
PCR amplification and cloning of the AaΦ23 int gene. By using the primers intL and intR, 
it has been possible to amplify a fragment of approximately 1,400 bp in size (Figure 17). The 
size of this fragment is slightly shorter than the size of 1,692 bp manually determined using 
the previously established nucleotide sequence of the integrase gene (Figure 18). Explanation 
for this observation may be obtained by the sequencing of the PCR products. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21226 bp 
5148 bp 
2027 bp 
1584 bp 
1375 bp 
947 bp 
DNA Ladder 
intL/intR PCR 
product 
~1400 bp 
Figure 17. PCR products obtained by amplification  
 
of the AaΦ23 genomic region between primers intL and intR. 
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GTTTGGTATCGCGTCATAAATGCCGTGTTTTTCGACAAAAATCACTGCAAAAAGGCGTACGAAAGCGAAATTAATCGCCGACA 
  intL 
ATACACTCAGGACTTTCAATAGCAAAAAAACGGCGGGTAATGTCGTGAAGTGTCATTTTATTTTCCTCGTTTTATGAGGTTTG 
 
CATGTGTGTTGATGTGTGCCATATTTGTGCCATTGATAAACGGCTAACTGCTGCTATTTGCTTCTGATGACTACGATTAATTT 
 
ATAAGCAAGAGGCGTAAGGCATTGTTTTACAATGATTTATGTATAGGCTTTCAAATATGGCATTCAAGAGGTCGTCGGTTCGA 
          attP core 
 
TCCCGATTATCTCCACCAAATTTTATAGCTTTATCAATTAGTTAGTTATTGATAAGGTTTTTTCCTCTTTGTGTTTGTGCCAA 
 
TTTTGTGGCAAAAAGTTGAACATTGTTGGCGTGGTTTTGTAAATGCTCAACAGATAAATGCGCATATTTTCTCACGGTGTCTG 
 
ATTTACTCCACCCGCCCAACTCTTGCAGCACATATAACGGCGTTCCCGACATAATGTGTCTTGTCGCCCAAGTATGGCGCAAG 
 
TCGTGAAAACGGAAGTCTTTGATTCCAGCTCGTTGTAATGCCGCACGGAACGCTTTAGTGTTTGCAATGCGAACCGGCTTGCC 
 
TTTATATGTGAACACGTTTTCTTTGTGCTTGCCAAATTGTGATACAATCACTTCAATAGCTTTGTCGTTTAACGGTACGCCAA 
 
TGCTATTACCTGTTTTTGATTGTTCCGAATTTATCCAAGCCTGTCTTTTGGATAAGTCAATTTGCGACCATTTTAGCTGGGTG 
 
ATGTTCGACATTCTTAACCCAGTCAAAATAGCAAATTGAACAATTGGCTTTAAGTGCTCCGGCAATTCTTCTATGAGCCTTAT 
 
TTCTTCGTGTTGGGTCAACCATCGTACACGTCGTTTGGGTTCAGGTAAGAATTTTATTGCTGGGCATTTATCCAACCAATCCC 
 
ACTCAACCGCCGCTCTTAATATCACTCTTATCTGCTGCAAAACGGCATTAATTGTTCTTGCCTTAACGCCTTCCTTCGCTTTT 
 
TCATATTGGATGAATTTTATTAAAGTGCGGTCAATTTCGTTGAGTTTTTTATCACCAAGATATTTATCAAGCCATACTAACCC 
 
GTAAAGCATGTTTCTATCTTGTTTGCGCTTTGGCTTTTCATCAAGCCATTGTACTACGGCTTCCTGCCAGGAATAATTTGGGC 
 
GCTCACCAAGTTTAAATACTCGCCAGCATTCGTTATATTCCTTTGAGGCTAATTGCTGCGCTTGATTTTTGTCTGAAGTCCTA 
 
GCGCTTCGGCGTACGCGCTCACCATTTGGCGACGTGAACGAGTAATGCCAGATTTCCCCTCTTTTCTTGAGGGAGATGATTTG 
 
ACGTGACATATATTCTCCTTATGCCCCGCCTCTTGCTCGGGGTGATCTTTATCCTTTTTCAAGAATTTTTCAAGCTCTTCAAC 
         Pint 
 
ATCAAATTTCCATTTTCTGCCGATCTTGTAAGCGGGTATTTCTTCTTTGTTTGCCATCTCCCGTAGTGTGACGGGGTGCATAT 
 
CAAGGATTCTTGCCGCTTTATCTGTGCCTATTAATTCCATAATTTCTCCAAAAATAAAGCCCATTTGTGCGCTTATTATCTAA 
 
TCAATATCACGGTTTAATATTTCGCTTATCTTGTCACCTGATTTCTGCTGAATGAAATCATTT 
       intR 
 
Figure 18. Nucleotide sequence of the previously identified gene coding for the putative integrase (Chapter I) of AaΦ23. 
The sequence is represented in the reversed orientation as on the entire AaΦ23 genomic sequence. Start and stop codons are 
boxed. Putative Int promoter (Pint) is underlined. The attP core sequence is indicated in bold italic. Hybridization sites of the 
primers intL and intR are in bold and underlined with arrows pointing in 5’ to 3’ orientation. 
 
Electroporation of the ligation mixture in A. actinomycetemcomitans ZIB1001. After 
electroporation of ZIB1001 with the ligation mixture (which might contain recombinant 
vectors pKT210::AaΦ23int), no colonies were obtained on BA plates containing 
chloramphenicol. However, colonies were observed when ZIB1001 was transformed with the 
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religated plasmid pKT210 indicating that the ligation process worked and that ZIB1001 cells 
were competents. Further efforts are needed for constructing an efficient integrative vector 
based on the integration elements of AaΦ23. 
 
CONCLUSIONS 
 
Two approaches were used in order to characterize the Integrase of AaΦ23. 
 
1. Identification of the AaΦ23 Int by in silico analysis of AaΦ23 ORF1. 
2. Cloning of the putative int gene, attP site and putative promoter pI into a plasmid. 
 
The indisponibility of a non-replicative vector adapted for cloning within A. 
actinomycetemcomitans obligates use to test our integration fragment with the Gram-negativ 
broad-host range pKT210 cloning vector. As expected, no colonies were obtained when 
ZIB1001 competent cells were transformed with pKT210::AaΦ23int meaning that this 
integrative vector integrates with high efficiency into ZIB1001 chromosome. Subsequent 
replication of the integrated vector within the host chromosome might be lethal for the cells. 
Nevertheless, no evidence that the pKT210::AaΦ23int recombinant vector was generated 
during the ligation process is available. Further studies using a non-replicative construct 
(generated for example by removing the origin of replication within pKT210) have to be done 
in order to characterize the Int activity. 
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GENERAL CONCLUSIONS AND PERSPECTIVES 
 
1. The AaΦ23 genome is composed of  43,033 bp and has an organization similar to that 
of lambdoid phages. Of 57 ORFs, 37 have no putative functions and 12 seem to be 
specific for AaΦ23. As more and more data are available every day it will be very 
interesting to compare regularly these ORFs with databases. By analogy to lambda, it 
can be speculated that within these 37 ORFs of unknown functions several structural 
component might found. In fact, lambda carries 21 genes involved in the formation of 
the virion protein structure, while in AaΦ23, only 5 genes coding for structural 
components were identified. Experiments using SDS-PAGE of phage particles may 
be useful in order to characterize additional structural components. 
2. The role of AaΦ23 in the virulence of A. actinomycetemcomitans is controversial. The 
work presented here shows that no protein with homologies to characterized phage-
encoded virulence factors is coded on the AaΦ23 genome. Nevertheless, orf20 codes 
for a functional DNA adenine methylase. It is well known that these enzymes play a 
role in the virulence of Salmonella typhimurium, Yersinia pseudotuberculosis and 
Vibrio cholerae. Whether the identified DNA adenine methylase plays a role in the 
pathogenesis of A. actinomycetemcomitans associated periodontitis remains to be 
determined. Limitations for this study might be the lack of a simple model for testing 
the virulence of A. actinomycetemcomitans. 
3. A putative integrase belonging to the family of integrase/recombinases has been 
identified on the AaΦ23 genome and the attP attachment site has been determined. 
New strategies may be applied in order to develop an integration vector based on the 
integration elements of phage AaΦ23. This vector will represent a useful tool for 
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genetic studies in A. actinomycetemcomitans. Moreover, an attB homologue sequence 
has been found in H. influenzae meaning that the integration vector could represent an 
A. actinomycetemcomitans/H. influenzae shuttle vector. 
4. A putative lytic system for AaΦ23 was identified. The lys gene was cloned in a 
cloning vector. All transformants carried the lys gene in the orientation which is not 
transcribed so that the lytic protein was not efficiously produced. This observation 
represents indirect evidence that lys codes for the lytic enzyme of AaΦ23. Further 
studies of this putative enzyme in systems allowing the complete suppression of 
background genetic expression might be of particular interest in order to purify this 
potential lytic protein. However, a therapeutic use of it in the treatment of A. 
actinomycetemcomitans mediated periodontitis is questionable. 
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